UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
10-Q
x
Quarterly
Report
Pursuant to Section 13 or 15(d) of the Securities
Exchange
Act of 1934
FOR
THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008
OR
o
Transition
Report
Pursuant to Section 13 or 15(d) of the Securities
Exchange
Act of 1934
For
the
transition period from _________ to _________
COMMISSION
FILE NUMBER 000-33199
AVENSYS
CORPORATION
(Exact
name of registrant as specified in its charter)
NEVADA
|
88-0467845
|
(State
of other jurisdiction of incorporation or
organization)
|
(IRS
Employer Identification Number)
|
|
|
400
Montpellier Blvd.
Montreal,
Quebec
Canada
H4N 2G7
(Address
of principal executive offices)
(514)
904-6030
(Registrant's
telephone number, including area
code)
|
Indicate
by check mark whether the registrant: (1) has filed all reports required
to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was
required
to file such reports), and (2) has been subject to such filing requirements
for
the past 90 days. Yes
x
No
o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting
company. See the definitions of “large accelerated filer”,
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act. (Check one):
Large
accelerated filer
o
|
Accelerated
filer
o
|
|
|
Non-accelerated
filer
o
|
Smaller
reporting company
x
|
(Do
not check if smaller reporting company)
|
|
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule
12b-2 of the Exchange Act). Yes
o
No
x
The
number of shares of the registrant's Common Stock, $0.00001 par value per
share,
outstanding as of November 11, 2008 was 99,086,152.
Avensys
Corporation
Interim
Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
|
Index
|
|
|
Interim
Consolidated Balance Sheets
|
F-1
|
|
|
Interim
Consolidated Statements of Operations and Comprehensive
Loss
|
F-2
|
|
|
Interim
Consolidated Statements of Cash Flows
|
F-3
|
|
|
Interim
Consolidated Statement of Stockholders’ Equity
|
F-5
|
|
|
Notes
to Interim Consolidated Financial Statements
|
F-6
|
Avensys
Corporation
|
Interim
Consolidated Balance Sheets
|
Unaudited
|
(Expressed
in U.S. Dollars)
|
|
|
September
30,
|
|
June
30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
ASSETS
|
|
|
|
|
|
|
|
Current
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
|
202,646
|
|
|
369,396
|
|
Accounts
receivable, net of allowance for doubtful accounts of $48,996 and
$50,053,
respectively
|
|
|
5,265,641
|
|
|
5,121,058
|
|
Other
receivables (Note 5)
|
|
|
1,966,661
|
|
|
1,924,767
|
|
Inventories
(Note 5)
|
|
|
2,310,780
|
|
|
2,178,686
|
|
Prepaid
expenses and deposits
|
|
|
153,682
|
|
|
149,213
|
|
Current
assets of discontinued operations (Note 4)
|
|
|
90,144
|
|
|
94,196
|
|
Total
Current Assets
|
|
|
9,989,554
|
|
|
9,837,316
|
|
|
|
|
|
|
|
|
|
Property
and equipment, net
|
|
|
2,288,118
|
|
|
2,490,215
|
|
Intangible
assets
|
|
|
3,585,100
|
|
|
3,879,086
|
|
Goodwill
|
|
|
4,450,637
|
|
|
4,644,864
|
|
Deferred
financing costs
|
|
|
379,691
|
|
|
404,630
|
|
Deposits
|
|
|
166,596
|
|
|
84,363
|
|
|
|
|
|
|
|
|
|
Total
Assets
|
|
|
20,859,696
|
|
|
21,340,474
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued liabilities (Note 5)
|
|
|
6,130,423
|
|
|
6,401,379
|
|
Bank
and other loans payable (Note 7)
|
|
|
3,271,753
|
|
|
2,431,948
|
|
Current
portion of long-term debt (Note 10)
|
|
|
122,618
|
|
|
122,423
|
|
Current
portion of balance of purchase price (Note 8)
|
|
|
91,125
|
|
|
92,818
|
|
Current
liabilities of discontinued operations (Note 4)
|
|
|
84,555
|
|
|
88,245
|
|
Total
Current Liabilities
|
|
|
9,700,474
|
|
|
9,136,813
|
|
|
|
|
|
|
|
|
|
Long-term
debt, less current portion (Note 10)
|
|
|
163,507
|
|
|
191,352
|
|
Convertible
debentures (Note 11)
|
|
|
1,493,733
|
|
|
1,299,412
|
|
Balance
of purchase price payable (Note 8)
|
|
|
1,383,263
|
|
|
1,706,363
|
|
Derivative
financial instruments (Note 9)
|
|
|
1,439,557
|
|
|
1,363,543
|
|
|
|
|
|
|
|
|
|
Total
Liabilities
|
|
|
14,180,534
|
|
|
13,697,483
|
|
Non-controlling
Interest
|
|
|
7,374
|
|
|
7,677
|
|
|
|
|
|
|
|
|
|
Stockholders’
Equity
|
|
|
|
|
|
|
|
Common
Stock, 500,000,000 shares authorized with a par value of $0.00001;
99,086,152 and 99,036,152 issued and outstanding,
respectively
|
|
|
990
|
|
|
990
|
|
Additional
Paid-in Capital
|
|
|
38,265,736
|
|
|
38,223,391
|
|
Accumulated
other comprehensive income
|
|
|
1,380,975
|
|
|
1,817,006
|
|
Deficit
|
|
|
(32,975,913
|
)
|
|
(32,406,073
|
)
|
|
|
|
|
|
|
|
|
Total
Stockholders’ Equity
|
|
|
6,671,788
|
|
|
7,635,314
|
|
|
|
|
|
|
|
|
|
Total
Liabilities and Stockholders’ Equity
|
|
|
20,859,696
|
|
|
21,340,474
|
|
Going
Concern (Note 1)
Contingencies
(Note 15)
(The
Accompanying Notes are an Integral Part of the Consolidated Financial
Statements)
Avensys
Corporation
|
Interim
Consolidated Statements of Operations and Comprehensive
Loss
|
Unaudited
|
(Expressed
in U.S. Dollars)
|
|
|
For
the Three Months Ended
|
|
|
|
September
30,
|
|
|
|
2008
|
|
2007
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Revenue
|
|
|
5,691,250
|
|
|
4,798,008
|
|
|
|
|
|
|
|
|
|
Cost
of Revenue
|
|
|
3,930,061
|
|
|
2,749,392
|
|
|
|
|
|
|
|
|
|
Gross
Margin
|
|
|
1,761,189
|
|
|
2,048,616
|
|
|
|
|
|
|
|
|
|
Operating
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
231,282
|
|
|
208,891
|
|
Selling,
general and administration
|
|
|
1,770,159
|
|
|
1,564,008
|
|
Research
and development
|
|
|
396,782
|
|
|
464,311
|
|
Total
Operating Expenses
|
|
|
2,398,223
|
|
|
2,237,210
|
|
|
|
|
|
|
|
|
|
Loss
from Operations
|
|
|
(637,034
|
)
|
|
(188,594
|
)
|
|
|
|
|
|
|
|
|
Other
Income (Expenses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expenses), net
|
|
|
1,724
|
|
|
11,951
|
|
Loss
on redemption of convertible debentures
|
|
|
-
|
|
|
(1,422,577
|
)
|
Interest
expense, net
|
|
|
(74,788
|
)
|
|
(308,980
|
)
|
Debentures
and balance of purchase price accretion (Note 8)
|
|
|
(302,568
|
)
|
|
(226,536
|
)
|
Loss
on extinguishment of debt (Note 8)
|
|
|
(47,044
|
)
|
|
-
|
|
Change
in fair value of derivative financial instruments (Note 9)
|
|
|
332,136
|
|
|
(271,829
|
)
|
Total
Other Income (Expenses)
|
|
|
(90,540
|
)
|
|
(2,217,971
|
)
|
Net
Loss Before Income Tax Benefit
|
|
|
(727,574
|
)
|
|
(2,406,565
|
)
|
|
|
|
|
|
|
|
|
Income
Tax Benefit - Refundable tax credits (Note 16)
|
|
|
157,752
|
|
|
169,001
|
|
|
|
|
|
|
|
|
|
Net
Loss before Non-Controlling Interest
|
|
|
(569,822
|
)
|
|
(2,237,564
|
)
|
|
|
|
|
|
|
|
|
Non-Controlling
Interest
|
|
|
(18
|
)
|
|
(139
|
)
|
Net
Loss from Continuing Operations
|
|
|
(569,840
|
)
|
|
(2,237,703
|
)
|
|
|
|
|
|
|
|
|
Results
of Discontinued Operations (Note 4)
|
|
|
-
|
|
|
95,851
|
|
Net
Loss
|
|
|
(569,840
|
)
|
|
(2,141,852
|
)
|
|
|
|
|
|
|
|
|
Basic
and diluted earnings (loss) per share
|
|
|
|
|
|
|
|
From
Continuing Operations
|
|
|
(0.01
|
)
|
|
(0.02
|
)
|
From
discontinued operations
|
|
|
-
|
|
|
-
|
|
Net
Loss per share - Basic and Diluted
|
|
|
(0.01
|
)
|
|
(0.02
|
)
|
Weighted
Average Common Shares Outstanding
|
|
|
99,072,565
|
|
|
95,212,000
|
|
|
|
|
|
|
|
|
|
Statement
of Comprehensive Loss
|
|
|
|
|
|
|
|
Net
Income (Loss)
|
|
|
(569,840
|
)
|
|
(2,141,852
|
)
|
Foreign
currency translation adjustments
|
|
|
(436,031
|
)
|
|
781,187
|
|
Comprehensive
Loss
|
|
|
(1,005,871
|
)
|
|
(1,360,665
|
)
|
Going
Concern (Note 1)
Contingencies
(Note 15)
(The
Accompanying Notes are an Integral Part of the Consolidated Financial
Statements)
Avensys
Corporation
|
Interim
Consolidated Statements of Cash Flows
|
Unaudited
|
(Expressed
in U.S. Dollars)
|
|
|
For
the Three Months Ended
|
|
|
|
September
30,
|
|
|
|
2008
|
|
2007
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Net
Loss
|
|
|
(569,840
|
)
|
|
(2,141,852
|
)
|
|
|
|
|
|
|
|
|
Results
of discontinued operations
|
|
|
-
|
|
|
(95,851
|
)
|
Adjustments
to reconcile net loss to cash generated by (used in) operating activities
|
|
|
|
|
|
|
|
Stock-based
compensation
|
|
|
42,345
|
|
|
112,039
|
|
Expenses
settled with issuance of common shares
|
|
|
-
|
|
|
17,500
|
|
Depreciation
and amortization
|
|
|
306,129
|
|
|
297,351
|
|
Non-cash
financial and other expenses
|
|
|
147,056
|
|
|
38,110
|
|
Non-controlling
interest
|
|
|
18
|
|
|
139
|
|
Loss
on redemption of convertible debentures
|
|
|
-
|
|
|
1,422,577
|
|
Loss
on extinguishment of debt (Note 8)
|
|
|
47,044
|
|
|
-
|
|
Debentures
and balance of purchase price accretion
|
|
|
302,568
|
|
|
226,536
|
|
Change
in fair value of derivative financial instruments
|
|
|
(332,136
|
)
|
|
271,829
|
|
Amortization
of deferred financing costs
|
|
|
23,846
|
|
|
23,588
|
|
Changes
in operating assets and liabilities
|
|
|
|
|
|
|
|
(Increase)
in accounts receivables
|
|
|
(274,125
|
)
|
|
(54,615
|
)
|
(Increase)
in inventories
|
|
|
(309,463
|
)
|
|
(197,672
|
)
|
(Increase)
decrease in other receivables
|
|
|
(157,752
|
)
|
|
174,507
|
|
(Increase)
in prepaid expenses and other assets
|
|
|
(103,386
|
)
|
|
(47,057
|
)
|
Increase
(decrease) in accounts payable and accrued liabilities
|
|
|
23,415
|
|
|
(584,897
|
)
|
Net
Cash Generated by (Used In) Operating Activities from Continuing
Operations
|
|
|
(854,281
|
)
|
|
(537,768
|
)
|
Net
Cash Generated by (Used In) Operating Activities from Discontinued
Operations
|
|
|
-
|
|
|
347,495
|
|
Net
Cash (Used In) Operating Activities
|
|
|
(854,281
|
)
|
|
(190,273
|
)
|
|
|
|
|
|
|
|
|
Investing
Activities
|
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(50,162
|
)
|
|
(88,516
|
)
|
Disposal
of property and equipment
|
|
|
-
|
|
|
36,484
|
|
Net
Cash Generated by (Used in) Investing Activities from Continuing
Operations
|
|
|
(50,162
|
)
|
|
(52,032
|
)
|
Net
Cash Generated by (Used in) Investing Activities
|
|
|
(50,162
|
)
|
|
(52,032
|
)
|
|
|
|
|
|
|
|
|
Financing
Activities
|
|
|
|
|
|
|
|
Proceeds
(repayment) of bank and working capital credit line
|
|
|
842,806
|
|
|
64,524
|
|
Repayment
of convertible debentures
|
|
|
-
|
|
|
(136,722
|
)
|
Proceeds
from issue of senior secured convertible debentures (Note 11)
|
|
|
-
|
|
|
3,726,621
|
|
Redemption
of secured convertible debentures
|
|
|
-
|
|
|
(3,440,421
|
)
|
Long
term debt proceeds
|
|
|
-
|
|
|
(20,098
|
)
|
Long
term debt repayments
|
|
|
(19,158
|
)
|
|
-
|
|
Proceeds
from investment tax credit financing
|
|
|
-
|
|
|
570,071
|
|
Repayments
of investment tax credit financing
|
|
|
-
|
|
|
(94,509
|
)
|
Proceeds
from capital leases
|
|
|
15,647
|
|
|
1,927
|
|
Repayments
of capital leases
|
|
|
(8,561
|
)
|
|
(5,282
|
)
|
Net
Cash Generated by Financing Activities from Continuing Operations
|
|
|
830,734
|
|
|
666,111
|
|
Net
Cash Generated by (Used in) Financing Activities from Discontinued
Operations
|
|
|
-
|
|
|
(406,335
|
)
|
Net
Cash Generated by Financing Activities
|
|
|
830,734
|
|
|
259,776
|
|
Effect
of Exchange Rate Changes on Cash and Cash Equivalents
|
|
|
(93,041
|
)
|
|
167,055
|
|
(Decrease)
Increase in Cash and Cash Equivalents
|
|
|
(166,750
|
)
|
|
184,526
|
|
|
|
|
|
|
|
|
|
Cash
and Cash Equivalents – Beginning of period
|
|
|
369,396
|
|
|
481,023
|
|
|
|
|
|
|
|
|
|
Cash
and Cash Equivalents – End of period
|
|
|
202,646
|
|
|
665,549
|
|
Going
Concern (Note 1)
Contingencies
(Note 15)
(The
Accompanying Notes are an Integral Part of the Consolidated Financial
Statements)
Avensys
Corporation
|
Interim
Consolidated Statements of Cash Flows (continued)
|
Unaudited
|
(Expressed
in U.S. Dollars)
|
|
|
For
the Three Months Ended
|
|
|
|
September
30,
|
|
|
|
2008
|
|
2007
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Non-Cash
Financing and Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares for repayment of secured convertible notes, Series
B
|
|
|
-
|
|
|
52,192
|
|
Issuance
of common shares pursuant to cashless exercise of warrants
|
|
|
-
|
|
|
28
|
|
Issuance
of stock options for debt settlement
|
|
|
|
|
|
|
|
Issuance
of common shares to settle outstanding payables
|
|
|
-
|
|
|
17,500
|
|
Supplemental
Disclosures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
(paid) earned from continuing operations
|
|
|
(60,858
|
)
|
|
(72,337
|
)
|
Going
Concern (Note 1)
Contingencies
(Note 15)
(The
Accompanying Notes are an Integral Part of the Consolidated Financial
Statements)
Avensys
Corporation
|
Interim
Consolidated Statement of Stockholders’ Equity
|
Unaudited
|
(Expressed
in U.S. Dollars)
|
|
|
|
|
|
|
Additional
|
|
|
|
Accumulated
Other
|
|
|
|
Total
|
|
|
|
Common Shares
|
|
Paid-In
|
|
Deferred
|
|
Comprehensive
|
|
|
|
Stockholders’
|
|
|
|
Number of
|
|
Amount
|
|
Capital
|
|
Compensation
|
|
Income
|
|
Deficit
|
|
Equity
|
|
|
|
Shares
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Balance,
June 30, 2007
|
|
|
93,437,654
|
|
|
934
|
|
|
36,727,893
|
|
|
-
|
|
|
1,268,622
|
|
|
(29,285,550
|
)
|
|
8,711,899
|
|
Stock-based
compensation
|
|
|
-
|
|
|
-
|
|
|
249,479
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
249,479
|
|
Common
stock issued to settle outstanding payables
|
|
|
250,000
|
|
|
3
|
|
|
17,497
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
17,500
|
|
Issuance
of Senior Secured Convertible OID Note
|
|
|
-
|
|
|
-
|
|
|
1,176,383
|
|
|
|
|
|
-
|
|
|
-
|
|
|
1,176,383
|
|
Common
stock issued pursuant to repayments of Secured Convertible Notes
Series
B
|
|
|
649,955
|
|
|
6
|
|
|
52,186
|
|
|
|
|
|
-
|
|
|
-
|
|
|
52,192
|
|
Common
stock issued pursuant to cashless exercise of warrants
|
|
|
2,759,235
|
|
|
28
|
|
|
(28
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Common
stock issued to settle placement agent fees on issuance of Senior
Secured
Convertible OID Note
|
|
|
1,477,273
|
|
|
15
|
|
|
(15
|
)
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Common
stock issued to settle a pricing adjustment shortfall in connection
with
the acquisition of the manufacturing assets of ITF Optical Technologies
Inc.
|
|
|
462,035
|
|
|
4
|
|
|
(4
|
)
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
548,384
|
|
|
|
|
|
548,384
|
|
Net
loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,120,523
|
)
|
|
(3,120,523
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
June 30, 2008
|
|
|
99,036,152
|
|
|
990
|
|
|
38,223,391
|
|
|
-
|
|
|
1,817,006
|
|
|
(32,406,073
|
)
|
|
7,635,314
|
|
Balance,
June 30, 2008
|
|
|
99,036,152
|
|
|
990
|
|
|
38,223,391
|
|
|
-
|
|
|
1,817,006
|
|
|
(32,406,073
|
)
|
|
7,635,314
|
|
Stock-based
compensation
|
|
|
-
|
|
|
-
|
|
|
42,345
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
42,345
|
|
Common
stock issued in connection with the exercise of stock options under
the
Company’s nonqualified employee stock option plan
|
|
|
50,000
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
Translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(436,031
|
)
|
|
|
|
|
(436,031
|
)
|
Net
loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(569,840
|
)
|
|
(569,840
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
September 30, 2008
|
|
|
99,086,152
|
|
|
990
|
|
|
38,265,736
|
|
|
-
|
|
|
1,380,975
|
|
|
(32,975,913
|
)
|
|
6,671,788
|
|
Going
Concern (Note 1)
Contingencies
(Note 15)
(The
Accompanying Notes are an Integral Part of the Consolidated Financial
Statements)
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
The
accompanying financial statements have been prepared using generally accepted
accounting principles applicable to a going concern, which assumes Avensys
Corporation (the “Company”) will be able to realize the carrying value of its
assets and discharge its liabilities in the normal course of operations.
The
Company has incurred significant losses since inception and has relied on
non-operational sources of financing to fund operations. Furthermore, the
Company’s operating subsidiary, Avensys Inc. (“AVI”), maintains a line of credit
from a financial institution, and the covenants pertaining to such were not
respected as at September 30, 2008. This constitutes an event of default
and
could result in the financial institution requiring repayment of a loan.
The
failed covenants with the financial institution triggered cross-default clauses
affecting the Company’s Working Capital Facility (Note 7(a)) and Senior Secured
Convertible Debenture (Note 11). Subsequent to September 30, 2008, the Company
has obtained waivers with respect to such cross-default clauses for the Working
Capital Facility and Senior Secured Convertible Debenture. AVI is seeking
to
renegotiate the credit agreement with the financial institution and is also
seeking to obtain additional conventional bank credit-line financing to that
which it already has, to support its growing operations. The material
uncertainties resulting from the above events and conditions are such that
there
exists substantial doubt that the Company would be able to continue as a
going
concern at September 30, 2008. The Company’s continuation as a going concern is
dependent upon the continued support of shareholders, lenders and suppliers
and
its ability to obtain additional cash to allow for the satisfaction of its
obligations on a timely basis.
Management
has taken steps to revise the Company’s operating and financial requirements.
During the first quarter of fiscal 2009, as described in Note 8, the Company
amended an agreement with the former shareholders of ITF Optical Technologies.
The amendment postponed, by 18 months, the exercise date of a put option
that
could have required the cash outlay of CAD $2,000,000 or the issuance of
CAD
$1,500,000 in Company shares at a reference share price of $0.342 between
April
and October 2009. The amended agreement stipulates:
|
·
|
The
date permitting the exercise of the put option by the ITF Preferred
Shareholders is postponed by 18 months from April 1, 2009 to October
1,
2010. The date at which the put option expires has also been postponed
from October 1, 2009 to December 31,
2010.
|
|
·
|
AVI
will pay interest at 10% annually from April 1, 2009 until the
date of
exercise of the put option on each ITF Preferred Shareholder’s
proportional share of the consideration, should they choose to
exercise
their option.
|
|
·
|
AVI
will also raise the total amount of the share consideration from
CAD
$1,500,000 to CAD $2,000,000 and will reduce the reference price
from
$0.342 to $0.11, should the Preferred Holders choose to exercise
the put
option for their proportionate amount of common shares of the
Company.
|
While
management believes the use of the going concern assumption is appropriate,
there is no assurance the above actions will be successful. These financial
statements do not include any adjustments or disclosures that may be necessary
should the Company not be able to continue as a going concern. If the use
of the
going concern assumption is not appropriate for these financial statements,
then
adjustments may be necessary to the carrying value and classification of
assets
and liabilities and reported results of operations and such adjustments could
be
material.
The
Company was incorporated in the State of Nevada on June 26, 2000 as Keystone
Mines Limited. The Company subsequently changed its name to C-Chip Technologies
Corporation. In July 2005, the Company changed its name to Manaris Corporation,
and in December 2007, to Avensys Corporation. The Company has achieved
significant revenue from acquired companies and also has disposed of companies.
The Company’s assets and operations at September 30, 2008 are located across
Canada. The Company currently derives all of its revenues from its subsidiary.
As discussed in Note 17, the Company operates two reporting segments, Fiber
Technologies and Solutions, corresponding to the Avensys Technologies and
Avensys Solutions divisions of AVI, as follows:
|
·
|
Avensys
Tech manufactures and distributes fiber optical components and
sensors
worldwide to the telecommunications, industrial laser and sensor
markets.
|
|
·
|
Avensys
Solutions distributes and integrates environmental monitoring solutions
in
both the public and private sectors of the Canadian
marketplace.
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
3.
|
Basis
of Presentation and Significant Accounting
Policies
|
Basis
of
Presentation
These
consolidated financial statements are prepared in conformity with accounting
principles generally accepted (“GAAP”) in the United States of America (“US”)
and are presented in US dollars, the reporting currency.
Interim
Financial Information
The
financial information presented as at September 30, 2008 and for the three
month
periods ended September 30, 2008 and 2007 is unaudited. In the opinion of
management, all adjustments necessary to present fairly the results of these
periods have been included. The adjustments made were of a normal-recurring
nature. The results of operations for the three month period ended September
30,
2008 are not necessarily indicative of the operating results anticipated
for the
full year. The financial statements follow the same accounting principles
and
methods of their application as the financial statements for the year ended
June
30, 2008. Other than for elements described in Recent Accounting Pronouncements
below, significant accounting policies of the Company are consistent with
those
described in the notes to the audited consolidated financial statements of
June
30, 2008.
Advertising
The
Company’s advertising costs, which amounted to $12,795 for the quarter ended
September 30, 2008 and $4,304 for the quarter ended September 30, 2007 are
expensed as incurred.
Foreign
Currency
The
functional currency of the Company is the U.S. dollar. The functional currency
of the Company’s Canadian subsidiary, AVI, is the Canadian dollar. Accordingly,
the financial statements of AVI are converted into the reporting currency
(the
US dollar) using the current rate method as follows: assets and liabilities
are
converted at the exchange rate in effect at the date of the balance sheet,
and
revenue and expenses are converted using the average exchange rate for the
period. All gains and losses resulting from the conversion are included in
other
comprehensive income or loss for the period and accumulated in a separate
component of stockholders’ equity as accumulated other comprehensive income or
loss.
Transactions
concluded in foreign currencies are converted into the functional currency
using
the exchange rate in effect at the date of the transaction or the average
rate
for the period in the case of recurring revenue and expense transactions.
Monetary assets and liabilities are revalued into the functional currency
at
each balance sheet date using the exchange rate in effect at that date, with
any
resulting exchange gains or losses being credited or charged to the statement
of
operations. Non-monetary assets and liabilities are recorded in the functional
currency using the exchange rate in effect at the date of the transaction
and
are not revalued for subsequent changes in exchange rates.
Deferred
Financing Fees
Costs
incurred in connection with financing activities are deferred and amortized
using the straight-line basis over the expected life of the related agreements
ranging from one to five years. Amortization of these costs is charged to
interest expense in the accompanying consolidated statements of operations
and
comprehensive loss. During the quarter ended September 30, 2007, the Company
wrote-off approximately $371,000 of deferred financing costs associated with
the
redemption of Series B Subordinated Secured Convertible Debentures, which
are
included in loss on redemption of convertible debentures in the consolidated
statement of operations and comprehensive loss.
Research
and Development Expenses and Investment Tax Credits
Research
and development expenses are expensed as they are incurred. Investment tax
credits (“ITCs”) arising from research and development activities are accounted
for as a reduction of the income tax provision for the year. Refundable tax
credits and non-refundable tax credits are recorded in the year in which
the
related expenses are incurred. A valuation allowance is provided against
such
tax credits to the extent that the recovery is not considered to be more
likely
than not.
The
Company is subject to examination by taxation authorities in various
jurisdictions. The determination of tax liabilities and ITCs recoverable
involve
certain uncertainties in the interpretation of complex tax regulations. As
a
result, the Company provides potential tax liabilities and ITCs recoverable
based on management’s best estimates. Differences between the estimates and the
ultimate amounts of taxes and ITCs are recorded in earnings at the time they
can
be determined.
Basis
of
Presentation and Significant Accounting Policies (continued)
Recent
Accounting Pronouncements
|
a)
|
Recent
Accounting Pronouncements Adopted During Fiscal Year
2009
|
In
February 2007, FASB issued SFAS No.159, “The Fair Value Option for Financial
Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 permits companies the
option, at specified election dates, to measure financial assets and liabilities
at their current fair value, with the corresponding changes in fair value
from
period to period recognized in the income statement. Additionally, SFAS 159
establishes presentation and disclosure requirements designated to facilitate
comparisons between companies that choose different measurement attributes
for
similar assets and liabilities. SFAS 159 is effective as of the beginning
of the
first fiscal year that begins after November 15, 2007. The Company adopted
the
provisions of SFAS 159 beginning on July 1, 2008. The adoption of this standard
did not have a significant impact on the consolidated financial position
and
results of operations of the Company.
In
March
2008, FASB issued FASB Statement No. 161, “Disclosures about Derivative
Instruments and Hedging Activities” (“SFAS 161”). SFAS 161 requires disclosure
of the fair values of derivative instruments and their gains and losses in
a
tabular format. It also requires disclosure of additional information about
an
entity’s liquidity by requiring disclosure of derivative features that are
credit risk-related. Finally, it requires cross-referencing within footnotes
to
enable financial statement users to locate important information about
derivative instruments. SFAS 161 is effective for financial statements issued
for fiscal years and interim periods beginning after November 15, 2008. Earlier
adoption is permitted. The Company adopted the provisions of SFAS 161 beginning
on July 1, 2008 and presents the fair values and gains and losses of derivative
instruments in Note 9.
|
b)
|
Recent
Accounting Pronouncements Adopted During Fiscal Year
2008
|
The
Company, as required, adopted the provisions of Financial Accounting Standards
Board (“FASB”) Interpretation No. 48 “Accounting for Uncertainty in Income
Taxes” (“FIN 48”), an interpretation of FASB Statement No. 109 “Accounting for
Income Taxes” (“SFAS 109”), effective July 1, 2007. FIN 48 clarifies the
accounting for income taxes by prescribing a minimum recognition threshold
and a
measurement attribute for the financial statement recognition and measurement
of
a tax position taken or expected to be taken in a tax return. With respect
to a
minimum recognition threshold, FIN 48 requires that the Company recognize,
in
its financial statements, the impact of a tax position if that position is
more
likely than not of being sustained on an audit, based on the technical merits
of
the position. In addition, FIN 48 specifically excludes income taxes from
the
scope of Statement of Financial Accounting Standards No. 5, “Accounting for
Contingencies”. FIN 48 applies to all tax positions related to income taxes that
are subject to SFAS 109, including tax positions considered to be routine.
As a
result of the implementation, no adjustment was required to the amount of
the
unrecognized tax benefits.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Basis
of
Presentation and Significant Accounting Policies (continued)
Recent
Accounting Pronouncements (continued)
|
c)
|
Recent
Accounting Pronouncements Not Yet Adopted
|
The
following represent recent accounting pronouncements not yet adopted that
have
not been previously discussed in the notes to the audited financial statements
of June 30, 2008 or for which the Company is updating its description of
evaluation of impact.
In
December 2007, FASB issued SFAS No. 160, “Non-controlling Interests in
Consolidated Financial Statements – an amendment of ARB No. 51” (“SFAS
160”). SFAS 160 establishes new accounting and reporting standards for the
non-controlling interest in a subsidiary and for the deconsolidation of a
subsidiary. Specifically, SFAS 160 requires the recognition of a non-controlling
interest (minority interest) as equity in the consolidated financial statements
and separate from the parent’s equity. The amount of net income attributable to
the non-controlling interest will be included in consolidated net income
on the
face of the income statement. SFAS 160 clarifies that changes in a parent’s
ownership interest in a subsidiary that do not result in deconsolidation
are
equity transactions if the parent retains its controlling financial interest.
In
addition, SFAS 160 requires that a parent recognize a gain or loss in net
income
when a subsidiary is deconsolidated. Such gain or loss will be measured using
the fair value of the non-controlling equity investment on the deconsolidation
date. SFAS 160 also includes expanded disclosure requirements regarding the
interests of the parents and its non-controlling interest. SFAS is effective
for
fiscal years, and interim periods within those fiscal years, beginning on
or
after December 15, 2008. Earlier adoption is prohibited. The Company intends
to
adopt to adopt SFAS 160 effective January 1, 2009 and is currently evaluating
the impact of the adoption of the provisions of SFAS 160 on its consolidated
financial statements.
In
April
2008, FASB issued FASB Staff Position (FSP) FAS 142-3, “Determination of the
Useful Life of Intangible Assets,” to provide guidance for determining the
useful life of recognized intangible assets and to improve consistency between
the period of expected cash flows used to measure the fair value of a recognized
intangible asset and the useful life of the intangible asset as determined
under
Statement 142. The FSP requires that an entity consider its own historical
experience in renewing or
extending
similar arrangements. However, the entity must adjust that experience based
on
entity-specific factors under FASB Statement 142, Goodwill and Other Intangible
Assets.
FSP
FAS
142-3 is effective for fiscal years and interim periods that begin after
November 15, 2008. The Company intends to adopt FSP FAS 142-3 effective January
1, 2009 and to apply its provisions prospectively to recognized intangible
assets acquired after that date.
In
June
2008, FASB ratified a consensus opinion reached by the Emerging Issues Task
Force (EITF) on EITF Issue 08-4, “Transition Guidance for Conforming Changes to
Issue No. 98-5,” to provide transition guidance for conforming changes made to
the abstract for EITF Issue 98-5, “Accounting for Convertible Securities with
Beneficial Conversion Features or Contingently Adjustable Conversion Ratios,”
relating to EITF Issue 00-27, “Application of Issue No. 98-5 to Certain
Convertible Instruments,” and FASB Statement 150, Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity.
The
Company intends to adopt EITF Issue 08-4 effective June 30, 2009 and apply
its
provisions retrospectively to all periods presented in its financial statements.
The Company is in the process of evaluating the impact that the adoption
of the
EITF Issue will have on its financial statements.
Comparative
Financial Statements
The
comparative Consolidated Financial Statements have been reclassified from
statements previously presented to conform to the presentation adopted in
the
current year. The reclassifications are attributed to reporting for discontinued
operations.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
4.
|
Discontinued
Operations
|
As
described in the notes to the June 30, 2008 audited consolidated financial
statements of the Company:
|
·
|
The
operations of C-Chip Technologies Corporation (North America),
a
subsidiary of the Company (“C-Chip”) were ceased on February 6, 2008.
Starting in the third quarter of Fiscal 2008, the former operations
of
C-Chip were classified as discontinued operations as the Company
ceased to
derive any cash flows from the prior C-Chip
activities.
|
|
·
|
The
operations of Canadian Security Agency (2004) Inc. (“CSA”), a wholly-owned
subsidiary of the Company, have been classified as discontinued
operations
since the fourth quarter of Fiscal
2006.
|
The
carrying values of the major classes of assets and liabilities of discontinued
operations, included under the ‘Current assets of discontinued operations’ and
‘Current liabilities of discontinued operations’ captions in the consolidated
balance sheet, are as follows:
|
|
September 30, 2008
|
|
June 30, 2008
|
|
|
|
C-Chip
|
|
CSA
|
|
Total
|
|
C-Chip
|
|
CSA
|
|
Total
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Cash
and cash equivalents
|
|
|
30,171
|
|
|
520
|
|
|
30,691
|
|
|
31,560
|
|
|
589
|
|
|
32,149
|
|
Accounts
receivable
|
|
|
52,660
|
|
|
-
|
|
|
52,660
|
|
|
54,958
|
|
|
-
|
|
|
54,958
|
|
Prepaid
Expenses
|
|
|
6,793
|
|
|
-
|
|
|
6,793
|
|
|
7,089
|
|
|
-
|
|
|
7,089
|
|
Current
assets of discontinued operations
|
|
|
89,624
|
|
|
520
|
|
|
90,144
|
|
|
93,607
|
|
|
589
|
|
|
94,196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
Payable and accrued liabilities
|
|
|
84,555
|
|
|
-
|
|
|
84,555
|
|
|
88,245
|
|
|
-
|
|
|
88,245
|
|
Other
loans payable
|
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Current
liabilities of discontinued operations
|
|
|
84,555
|
|
|
-
|
|
|
84,555
|
|
|
88,245
|
|
|
-
|
|
|
88,245
|
|
Summary
results of discontinued operations for the three-month periods ended September
30, 2008 and 2007 are as follows:
|
|
Total
|
|
C-Chip
|
|
CSA
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Revenues
from discontinued operations
|
|
|
-
|
|
|
171,872
|
|
|
-
|
|
|
171,872
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax
earnings (loss) from Discontinued Operations
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
After
tax earnings (loss) from Discontinued Operations
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
-
|
|
Gain
on extinguishment of loan
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Results
of discontinued operations
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
95,851
|
|
|
-
|
|
|
-
|
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Other
Receivables
|
|
|
|
|
|
|
|
Investment
tax credits receivable
|
|
|
1,930,982
|
|
|
1,854,095
|
|
Sales
tax receivable
|
|
|
34,872
|
|
|
65,416
|
|
Other
|
|
|
807
|
|
|
5,256
|
|
|
|
|
1,966,661
|
|
|
1,924,767
|
|
Inventories
|
|
|
|
|
|
|
|
Raw
materials
|
|
|
929,120
|
|
|
905,988
|
|
Work
in process
|
|
|
543,995
|
|
|
314,105
|
|
Finished
goods
|
|
|
837,665
|
|
|
958,593
|
|
|
|
|
2,310,780
|
|
|
2,178,686
|
|
Accounts
Payable and Accrued Liabilities
|
|
|
|
|
|
|
|
Accounts
payable
|
|
|
3,971,883
|
|
|
4,085,102
|
|
Payroll
and benefits
|
|
|
1,336,964
|
|
|
1,801,437
|
|
Income
taxes payable
|
|
|
-
|
|
|
1,614
|
|
Rent
payable
|
|
|
-
|
|
|
36,200
|
|
Deferred
revenue
|
|
|
481,034
|
|
|
138,338
|
|
Lease
termination
|
|
|
23,414
|
|
|
24,408
|
|
Provision
for Warranty
|
|
|
299,694
|
|
|
282,234
|
|
Other
|
|
|
17,434
|
|
|
32,046
|
|
|
|
|
6,130,423
|
|
|
6,401,379
|
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
6.
|
Variable
Interest Entity
|
The
Financial Accounting Standards Board (“FASB”) finalized FASB Interpretation No.
46R, “Consolidation of Variable Interest Entities—An Interpretation of ARB51”
(“FIN46R”) in December 2003. FIN46R expands the scope of ARB51 and can require
consolidation of "variable interest entities” (“VIEs”). Once an entity is
determined to be a VIE, the primary beneficiary is required to consolidate
that
entity.
During
the year ended June 30, 2005, AVI transferred its research activities to AVI
Laboratories Inc. (“ALI”). AVI owned at the time 49% of ALI and the two entities
entered into an agreement (the “ALI Agreement”) whereby ALI would perform
research and development activities for AVI. The ALI Agreement was for a period
of five years with a two-year renewal period and calls for ALI to provide AVI
with a commercialization license for products developed in return for a royalty
of 5% of sales generated. AVI sold intellectual property related to research
& development projects to ALI for tax planning purposes in return for
500,000 preferred shares redeemable for $429,037 (CAD$500,000). ALI provided
research & development for AVI only. However, it may also have entered into
agreements with third parties. ALI has no financing other than amounts received
from AVI.
As
a
result of the above, ALI had been included in the consolidated financial
statements commencing in the year ended June 30, 2005 since AVI was the primary
beneficiary.
During
the year ended June 30, 2006, ALI purchased ITF Optical Technologies' R&D
assets as part of a business combination. As a result of the ITF Optical
Technologies transaction, AVI's ownership of the voting stock of ALI decreased
from 49% to 42%. Following this acquisition, ALI continues to qualify as a
VIE,
of which AVI is the primary beneficiary. Consequently, ALI will continue to
be
consolidated by AVI and the Company following the ITF Optical Technologies
transaction. Following this transaction, ALI changed its name to ITF
Laboratories Inc.
ITF
Laboratories Inc. (“ITF Labs”) provides research & development to AVI and
other parties. As a result, ITF Laboratories Inc. continues to be included
in
the consolidated financial statements of the Company for the three months ended
September 30, 2008, since AVI is the primary beneficiary. The impact of
including the accounts of ITF Laboratories Inc. in the consolidated balance
sheet as at September 30, 2008 consists of the following additions:
|
·
|
Current
assets of $3,454,457 (June 30, 2008 -
$2,785,075)
|
|
·
|
Net
property and equipment of $839,353 (June 30, 2008 -
$916,421)
|
|
·
|
Intangible
assets of $218,628 (June 30, 2008 -
$237,834)
|
|
·
|
Current
liabilities of $1,331,247 (June 30, 2008 -
$1,370,102)
|
The
impact on the consolidated statement of operations for three months ended
September 30, 2008 and 2007 was:
|
·
|
Increase
in revenue of $939,932 and $362,441,
respectively
|
|
·
|
Increase
in expenses of $1,137,194 and $542,818, respectively, including an
amount
for research and development expenses of $396,782 and $345,619,
respectively
|
|
·
|
Increase
in the income tax benefit from refundable investment tax credits
of
$157,752 and $176,589, respectively
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
7.
|
Bank
and Other Loans Payable
|
The
details of bank and other loans payable is as follows:
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Senior
Secured Working Capital Note of the Company, bearing interest at
8.5%,
maturing November 2, 2008 ($500,000), November 29, 2008 ($600,000)
and
January 1, 2009 ($500,000) (Note 7 (a))
|
|
|
1,600,000
|
|
|
1,000,000
|
|
Secured
bank line of credit of AVI, bearing interest at Canadian bank prime
rate
plus 1.5% (Note 7 (b))
|
|
|
1,028,851
|
|
|
843,540
|
|
Investment
tax credit financing of AVI, bearing interest at 18%, repayable on
demand
(Note 7 (c))
|
|
|
642,902
|
|
|
588,408
|
|
|
|
|
3,271,753
|
|
|
2,431,948
|
|
|
a)
|
In
connection with the issue of a Senior Secured Original Issue Discount
Convertible Debenture (Note 11), the Company obtained access to a
$2,500,000 Working Capital Facility (the “Facility”). On November 2, 2007,
the Company obtained $500,000 from the Facility in the form of a
Senior
Secured Working Capital Note (“WC Note”), bearing interest at 8.5% payable
at maturity, maturing on February 2, 2008. The Company renewed the
$500,000 WC Note on the same terms and the maturity date was extended
to
November 2, 2008 - the maturity date was subsequently extended to
January
2, 2009 with a payable balance of $510,861, representing the original
$500,000 WC Note including $10,861 of unpaid interest. On April 1,
2008,
the Company obtained an additional $500,000 WC Note from the Facility
bearing interest at 8.5% payable at maturity, maturing on July 1,
2008,
which was extended to January 1, 2009 on the same terms and conditions.
The Company obtained a further $600,000 WC Note from the Facility,
also
bearing interest at 8.5% payable at maturity, maturing on November
29,
2008. In the normal course of operations, these notes mature ninety
days
after issuance and are subject to maturity dates being extended and
the
notes are therefore renewed on maturity. As discussed in Note 1,
subsequent to September 30, 2008, the Company obtained a waiver,
from the
holder of the WC Notes, for a failed condition of the Facility which
resulted from the triggering of a cross-default
clause.
|
|
b)
|
AVI
maintains a line of credit from a financial institution for an authorized
amount of $1,277,955 (CAD$1,360,000), which bears interest at the
Canadian
bank prime rate plus 1.5%. The outstanding balance under the line
of
credit as at September 30, 2008 amounted to $1,028,851 (CAD $1,094,904)
(June 30, 2008 $843,540 - CAD $860,157). AVI’s accounts receivable
totaling $4,401,104 (CAD $4,683,655) and inventories totaling $1,790,211
(CAD $1,905,143) serve as guarantees for the line of credit. As discussed
in Note 1, according to terms of the credit agreement, AVI is subject
to
certain financial covenants which were not respected as at September
30,
2008.
|
|
c)
|
ITF
Labs obtained investment tax credit financing during the quarter
ended
September 30, 2007 in the amount of $588,408 (CAD $600,000). The
demand
loan bears interest at 18%, with interest payable on a monthly basis,
and
is secured by the Federal and Provincial tax credits receivables
and the
assets of ITF Labs. On July 30, 2008, ITF Labs refinanced the investment
tax credit loan at which time interest and fees were added to the
principal, resulting in a loan balance of $642,902 (CAD
$684,176).
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
8.
|
Balance
of Purchase Price Payable
|
Balance
of purchase payable is classified as a liability in the consolidated balance
sheet of the Company, measured at net present value and accreted to the face
amount using the effective interest rate method to the first date a payment
would be required. Balance of purchase price accretion is recorded in the
Statement of Operations The following table illustrates the book values of
these
balances of purchase price payable at June 30, 2008 and September 30,
2008:
|
|
|
|
|
|
|
|
Net Present Value at
|
|
|
|
Transaction
|
|
Maturity /
|
|
Effective
|
|
June
|
|
September
|
|
|
|
Date
|
|
Expiry Date
|
|
Interest Rate
|
|
30, 2008
|
|
30,
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Willer
Transaction (Note 8 (a))
|
|
|
03/31/2008
|
|
|
01/30/2009
|
|
|
10
|
%
|
|
92,818
|
|
|
91,125
|
|
Willer
Transaction (Note 8 (a))
|
|
|
03/31/2008
|
|
|
01/29/2010
|
|
|
10
|
%
|
|
84,470
|
|
|
82,926
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
177,288
|
|
|
174,051
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ITF
Transaction (Note 8 (b))
|
|
|
04/18/2006
|
|
|
04/01/2009
|
|
|
30
|
%
|
|
1,621,893
|
|
|
-
|
|
ITF
Transaction - Amendment (Note 8 (b))
|
|
|
09/11/2008
|
|
|
10/01/2010
|
|
|
30
|
%
|
|
-
|
|
|
1,300,337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,621,893
|
|
|
1,300,337
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
1,799,181
|
|
|
1,474,388
|
|
|
a)
|
As
part of the acquisition in 2008 of the net operating assets of Willer
Engineering Ltd (“Willer Transaction”), the Company has recorded a balance
of purchase price payable.
|
In
the
case of the Willer Transaction, the initial purchase price incurred for the
operating assets acquired included balances of purchase price payable, measured
at net present value and accreted to the face amount using an effective interest
rate of 10% to the dates payments would be first required - January 30, 2009
and
January 29, 2010.
|
b)
|
As
part of the acquisition in 2006 of the manufacturing and research
and
development assets of ITF Optical Technologies Inc. (“ITF Transaction”),
the Company entered into a shareholder agreement which stipulated
that,
between April 1, 2009 and October 1, 2009, each ITF Preferred Shareholder
shall have an option to (i) sell their shares in ITF Labs’ ownership to
AVI for its proportionate share of CAD $2,000,000 to be paid in cash,
or
(ii) exchange their shares in ITF Labs’ ownership for 3,826,531 freely
tradable shares of Company common shares at a reference per share
price of
$0.342; the equivalent of CAD $1,500,000 (the “put option”). The option of
the ITF Preferred Shareholders to sell their shares in ITF Labs ownership
to AVI was recorded as a balance of purchase price payable with an
embedded beneficial conversion feature, treated as a derivative liability
(Note 9). The balance of purchase price payable was measured at net
present value and accreted to the face amount using an effective
interest
rate of 30% to the first date a payment could be
required.
|
On
September 11, 2008, the Company and the ITF Preferred Shareholders amended
the
shareholder agreement described above as follows:
|
·
|
The
date permitting the exercise of the put option by the ITF Preferred
Shareholders is postponed by 18 months from April 1, 2009 to October
1,
2010. The date at which the put option expires has also been postponed
from October 1, 2009 to December 31,
2010.
|
|
·
|
Avensys
Inc. will also raise the total amount of the share consideration
from CAD
$1,500,000 to CAD $2,000,000, plus interest, and will reduce the
reference
price from $0.342 to $0.11, should the Preferred Holders choose to
exercise the put option for their proportionate amount of common
shares of
the Company.
|
|
·
|
AVI
will pay interest at 10% annually from April 1, 2009 until the date
of
exercise of the put option on each ITF Preferred Shareholder’s
proportional share of the consideration, should they choose to exercise
their options.
|
The
Company accounted for the amendment to the shareholder agreement as a debt
extinguishment in accordance with EITF issue 96-19. As such, the debt component
and the derivative liability component were re-evaluated as at September 11,
2008, to give effect to the amendment, and the carrying values were changed,
as
follows:
|
|
Carrying Value
|
|
|
|
|
|
Prior to
|
|
After
|
|
Gain (Loss) on
|
|
|
|
Amendment
|
|
Amendment
|
|
Extinguishment
|
|
|
|
|
|
|
|
|
|
Debt
Component
|
|
|
1,626,144
|
|
|
1,271,073
|
|
|
355,072
|
|
Derivative
Liability Component
|
|
|
710
|
|
|
402,826
|
|
|
(402,116
|
)
|
Total
|
|
|
1,626,854
|
|
|
1,673,899
|
|
|
(47,044
|
)
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
9.
|
Derivative
Financial Instruments
|
The
acquisition of the manufacturing and research and development assets of ITF
Optical Technologies Inc. in 2006, the issuance of Series B Subordinated Secured
Convertible Debentures in 2006, and the issuance of the Senior Secured Original
Issue Discount Convertible Debenture in 2007 each resulted in the recognition
of
derivative liabilities due to embedded conversion option features and warrants
present in the associated liabilities. These embedded conversion options and
warrants are classified as derivative liabilities and measured at fair value
using the Black-Scholes Model. Changes in fair values of derivative liabilities
are recorded in the Statement of Operations. The following table illustrates
the
values of the Company’s derivative liabilities at June 30, 2008 and September
30, 2008 and the resulting gain or loss recorded in the statement of
operations:
|
|
|
|
|
|
Value at
|
|
|
|
|
|
Maturity /
|
|
# of underlying
|
|
June
|
|
September
|
|
Gain (Loss) on
|
|
|
|
Expiry Date
|
|
Shares
|
|
30, 2008
|
|
30, 2008
|
|
Changes in Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior
Secured Convertible Debenture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series
P warrants
|
|
|
09/24/2012
|
|
|
8,091,403
|
|
|
226,032
|
|
|
187,673
|
|
|
38,359
|
|
Beneficial
Conversion Option - Convertible debenture
|
|
|
09/24/2012
|
|
|
39,516,148
|
|
|
1,086,304
|
|
|
921,192
|
|
|
165,112
|
|
|
|
|
|
|
|
|
|
|
1,312,336
|
|
|
1,108,865
|
|
|
203,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serie
B Subordinated Secured Convertible Debentures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series
Y Warrants
|
|
|
11/09/2010
|
|
|
145,005
|
|
|
2,628
|
|
|
1,987
|
|
|
641
|
|
Series
Z Warrants
|
|
|
11/09/2010
|
|
|
2,175,063
|
|
|
39,413
|
|
|
29,810
|
|
|
9,603
|
|
Series
W Warrants (placement fees)
|
|
|
11/09/2010
|
|
|
711,490
|
|
|
2,886
|
|
|
1,721
|
|
|
1,165
|
|
Series
Y Warrants (placement fees)
|
|
|
11/09/2010
|
|
|
17,789
|
|
|
322
|
|
|
244
|
|
|
78
|
|
Series
Z Warrants (placement fees)
|
|
|
11/09/2010
|
|
|
266,810
|
|
|
4,835
|
|
|
3,657
|
|
|
1,178
|
|
|
|
|
|
|
|
|
|
|
50,084
|
|
|
37,419
|
|
|
12,665
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion
Option on Balance of Purchase Price (Note 8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ITF
Optical Technologies Inc. assets acquisition
|
|
|
04/01/2009
|
|
|
3,826,531
|
|
|
1,123
|
|
|
-
|
|
|
368
|
|
ITF
Optical Technologies Inc. assets acquisition (amended)
|
|
|
10/01/2010
|
|
|
20,074,832
|
|
|
-
|
|
|
293,273
|
|
|
115,632
|
|
|
|
|
|
|
|
|
|
|
1,123
|
|
|
293,273
|
|
|
116,000
|
|
Total
|
|
|
|
|
|
|
|
|
1,363,543
|
|
|
1,439,557
|
|
|
332,136
|
|
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Mortgage
loan secured by AVI's intangible and movable tangible assets (September
30, 2008 - CAD $182,000; June 30, 2008 - CAD $203,000), bearing interest
at the lender's prime rate (September 30, 2008 - 6.25%; June 30,
2008 -
6.75%) plus 1.75%, payable in monthly instalments of CAD$7,000 plus
interest, maturing in November 2010
|
|
|
171,020
|
|
|
199,079
|
|
|
|
|
|
|
|
|
|
Capital
lease obligations (September 30, 2008 - CAD $99,777; June 30, 2008
- CAD
$92,396), bearing interest between 9.07% and 16.23%, maturing between
February 2010 and April 2012
|
|
|
93,758
|
|
|
90,610
|
|
|
|
|
|
|
|
|
|
Secured
note (September 30, 2008 - CAD $22,718; June 30, 2008 - CAD $24,560)
bearing no interest, payable in 48 monthly instalments of $614, maturing
October 2011.
|
|
|
21,347
|
|
|
24,086
|
|
|
|
|
286,125
|
|
|
313,775
|
|
Less:
Current portion of long-term debt
|
|
|
122,618
|
|
|
122,423
|
|
Long-term
debt
|
|
|
163,507
|
|
|
191,352
|
|
Remaining
principal payments, by fiscal year, on long-term debt and capital
leases
are as follows:
|
|
|
$
|
|
|
|
|
|
|
2009
|
|
|
91,532
|
|
2010
|
|
|
120,545
|
|
2011
|
|
|
64,165
|
|
2012
|
|
|
9,883
|
|
2013
|
|
|
-
|
|
Total
|
|
|
286,125
|
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
11.
|
Convertible
Debenture
|
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
Senior
Secured Original Issue Discount Convertible Debenture at 6% (original
principal amount of $4,000,000) maturing September 24,
2012.
|
|
|
1,493,733
|
|
|
1,299,412
|
|
Principal
payments on the convertible debenture for the next five fiscal years are as
follows:
|
|
$
|
|
2009
|
|
|
-
|
|
2010
|
|
|
1,177,225
|
|
2011
|
|
|
1,569,633
|
|
2012
|
|
|
1,569,633
|
|
2013
|
|
|
392,409
|
|
|
|
|
4,708,900
|
|
Less:
Impact of accretion / present value
|
|
|
3,215,167
|
|
Total
|
|
|
1,493,733
|
|
During
the first quarter of fiscal 2008, the Company received a $3.4 million secured
loan facility from Imperium Master Fund, LTD (the “Investor”) in connection with
the redemption of previously issued convertible debentures. The terms of the
loan facility state that interest will be paid by the Company on the unpaid
principal amount at an annual rate equal to 8.5%. It was the intention of the
Company and the Investor to replace the secured loan facility with a
comprehensive refinancing to facilitate a capital restructuring that would
provide the Company with additional working capital and credit facilities.
On
September 24, 2007, the Company entered into a Securities Purchase and Loan
Agreement (“SPL Agreement”) with the Investor for the sale of a 6% Senior
Secured Original Issue Discount Convertible Debenture (“Convertible Note”) in
the amount of $4,708,900. The principal value and the gross proceeds of the
Convertible Note is $4,000,000. The gross proceeds were used to repay the
secured loan facility of $3.4 million, being the amount which had been used
to
repay the previously issued convertible debentures, with the balance of funds,
$0.6 million, for the Company’s working capital purposes.
The
Convertible Debenture matures on September 24, 2012 and the original principal
amount is convertible into common shares of the Company at a conversion price
of
$0.11. The principal value will accrete to the value of the Convertible Note
over a two-year period and will subsequently accrue interest at 6%. Monthly
installments of principal and interest will be payable commencing after the
second year up to the maturity date. The SPL Agreement also provides the holder
of the Convertible Note with Series Q warrants to purchase, subject to
adjustment, 20,276,190 shares of the Company’s outstanding common stock on a
fully diluted basis. On August 22, 2007, the Company issued to the holder of
the
Convertible Note Series P warrants, representing compensation for advisory
services rendered to the Company, to purchase up to 5% of the Company’s
outstanding common stock, initially amounting to 8,091,403 shares and subject
to
adjustment, on a fully diluted basis. The warrants have an exercise price of
$0.11, subject to adjustment, and expire after five years. In addition, the
SPL
Agreement provides the Company with a $2,500,000 Working Capital Facility (Note
7 (a)).
In
accordance with EITF 00-19, EITF 05-2, EITF 05-4, FASB 133 and APB 14, the
Company allocated $479,816 to the Series P Warrants and recognized an embedded
conversion option feature of $1,711,199. The Series P warrants and the embedded
conversion option feature components are accounted for as derivative
liabilities. The Company allocated $162,500 and $53,624, respectively, to the
common stock and warrants issued to the placement agent, and allocated $960,259
to the Series Q warrants, all of which were recorded as additional paid-in
capital. The Company allocated the remaining proceeds to the Convertible
Debenture in the amount of $848,725. The carrying amount of the Convertible
Debenture will be increased by periodic accretion under the effective interest
method. The Company used the Black-Scholes option pricing model to value the
Series P warrants and the embedded conversion option feature, recorded as
derivative liabilities, at the issue date and uses the same model to value
these
elements on a quarterly basis. The Company recorded deferred financing costs
of
$446,124 at the issue date, representing common stock and warrants issued to
the
placement agent valued at $162,500 and $53,624, respectively, and cash fees
paid
of $230,000. These deferred financing costs are amortized on a straight-line
basis over the term of the Convertible Debenture. At September 30, 2008, the
outstanding principal amount on the Convertible Debenture was $4,346,776.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Convertible
Debenture (continued)
The
following table illustrates the values of the various components of the
financing at June 30, 2008 and September 30, 2008.
|
|
|
|
Maturity /
|
|
# of underlying
|
|
Value at June
|
|
Value at September
|
|
|
|
|
|
Expiry Date
|
|
Shares
|
|
30, 2008
|
|
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series
P warrants
|
|
|
09/24/2007
|
|
|
09/24/2012
|
|
|
8,091,403
|
|
|
226,032
|
|
|
187,673
|
|
Beneficial
Conversion Option - Convertible debenture
|
|
|
09/24/2007
|
|
|
09/24/2012
|
|
|
39,516,148
|
|
|
1,086,034
|
|
|
921,192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,312,066
|
|
|
1,108,865
|
|
Carrying
Value of Original Issue Discount
Senior
Secured Convertible Debenture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible
debenture
|
|
|
09/24/2007
|
|
|
09/24/2012
|
|
|
|
|
|
1,299,412
|
|
|
1,493,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
Paid-In Capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
stock issued for fees (1)
|
|
|
09/24/2007
|
|
|
|
|
|
|
|
|
162,500
|
|
|
162,500
|
|
Warrants
issued for fees
|
|
|
09/24/2007
|
|
|
|
|
|
1,936,937
|
|
|
53,624
|
|
|
53,624
|
|
Series
Q warrants
|
|
|
09/24/2007
|
|
|
|
|
|
20,276,190
|
|
|
960,259
|
|
|
960,259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,176,383
|
|
|
1,176,383
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
3,787,861
|
|
|
3,778,981
|
|
(1)
Common shares to the Placement Agent totaling 1,477,273 were issued in the
third
quarter of fiscal year 2008.
In
connection with this financing, specifically the shares to be delivered upon
potential conversion of the Convertible Debenture and the exercise of the
Warrants, the Company was obligated to file a registration statement with the
Securities and Exchange Commission (“SEC”). The Company’s registration
statement, filed with the SEC, became effective as of January 14, 2008.
To
secure
payment of the principal amount of the Convertible Note, the Company
hypothecated, in favor of the holder of the Convertible Debenture, the
universality of all of the immoveable and moveable assets, corporeal and
incorporeal, present and future of the Company.
The
Convertible Debenture contains events of default that would permit the Investor
to demand repayment.
The
SPL
Agreement with respect to this Convertible Debenture contains certain covenants
(a) related to the conduct of the business of the Company and its subsidiaries;
(b) related to certain financial covenants; (c) related to creation or
assumption of liens other than liens created pursuant to the SPL Agreement,
as
defined in the SPL Agreement; (d) for so long as this Note remains outstanding,
the Company shall not, without the consent of the holder of the Convertible
Debenture, create, incur, guarantee, issue, assume or in any manner become
liable in respect of any indebtedness, other than permitted indebtedness, or
issue other securities that rank senior to this Convertible Debenture provided
however that the Company could have a certain maximum amount of outstanding
bank
debt. At September 30, 2008, all the covenants contained within this Convertible
Debenture were respected, except as discussed in Note 1. Subsequent to September
30, 2008, the Company obtained a waiver from its lenders for a failed condition
of the Senior Secured Convertible Debenture which resulted from the triggering
of a cross-default clause.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
At
September 30, 2008, the Company had authority to issue 500,000,000 shares of
common stock. The Company had 99,086,152 common shares outstanding at September
30, 2008 compared to 99,036,152 on June 30, 2008. The company issued 50,000
shares on July 25, 2008 in connection with the exercise of stock options under
the Company’s nonqualified employee stock option plan.
13.
|
Common
Stock Reserved for Future Issuance
|
At
September 30, 2008 common stock of the Company, reserved for future issuance,
was as follows:
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
|
|
|
|
Stock Options (Note 14
(a))
|
|
|
|
|
|
|
|
Options
outstanding
|
|
|
10,236,773
|
|
|
10,036,773
|
|
Available
for awards
|
|
|
3,739,541
|
|
|
3,989,541
|
|
|
|
|
|
|
|
|
|
Stock
Plan (1)
|
|
|
|
|
|
|
|
Available
for awards
|
|
|
3,750,000
|
|
|
3,750,000
|
|
|
|
|
|
|
|
|
|
Warrants
(Note 14 (b))
|
|
|
44,125,399
|
|
|
44,125,399
|
|
|
|
|
|
|
|
|
|
Conversion
feature of OID Senior Secured Convertible Note
|
|
|
39,516,148
|
|
|
38,714,119
|
|
|
|
|
101,367,861
|
|
|
100,615,832
|
|
|
(1)
|
On
August 21, 2007, the Company filed an S-8 with the Securities and
Exchange
Commission establishing an Employee Compensation Plan (“Plan”). The Plan
is designed to retain employees, consultants, advisors and professionals
(“Participants”) and reward them for making major contributions to the
success of the Company. These objectives are accomplished by making
long-term incentive awards under the Plan thereby providing Participants
with a proprietary interest in the growth and performance of the
Company.
The Company registered 4,000,000 common shares for issuance under
the
Plan. In August 2007, the Company issued 250,000 common shares from
the
Plan as compensation for legal
services.
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
14.
|
Stock
Options and Warrants
|
Under
the
Avensys Corporation 2006 Nonqualified Stock Option Plan (“Plan”), the Company
may grant options to its Directors, Officers and employees for the acquisition
of up to 15,000,000 common shares. Stock options are generally granted with
an
exercise price equal to the common share’s fair market value at the date of
grant. Options are granted periodically and both the maximum term of an option
and the vesting period are set at the Board of Directors’ discretion. On
September 5, 2007, the Plan was amended and restated as the Amended and Restated
2006 Nonqualified Stock Option Plan and augmented by 5,000,000 stock options,
allowing the Company to issue options for the acquisition of up to 20,000,000
common shares.
During
the three months ended September 30, 2008, 250,000 stock options were granted
to
employees and directors with exercise prices equivalent to the market price
on
the respective grant dates (3,100,000 for the year ended June 30,
2008).
A
summary of the changes in the Company's common share stock options
is
presented below:
|
|
|
September 30, 2008
|
|
June 30, 2008
|
|
|
|
|
|
Weighted
|
|
|
|
Weighted
|
|
|
|
Number of
|
|
Average Exercise
|
|
Number of
|
|
Average Exercise
|
|
|
|
Options
|
|
Price ($)
|
|
Options
|
|
Price ($)
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
beginning of period
|
|
|
10,036,773
|
|
|
0.35
|
|
|
8,661,070
|
|
|
0.42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
250,000
|
|
|
0.07
|
|
|
3,100,000
|
|
|
0.09
|
|
Exercised
|
|
|
(50,000
|
)
|
|
0.00001
|
|
|
-
|
|
|
-
|
|
Forfeited
|
|
|
-
|
|
|
-
|
|
|
(1,724,297
|
)
|
|
(0.18
|
)
|
Balance
at end of period
|
|
|
10,236,773
|
|
|
0.35
|
|
|
10,036,773
|
|
|
0.35
|
|
Additional
information regarding options outstanding as at September 30, 2008 is as
follows:
|
|
Outstanding
|
|
Exercisable
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
average
|
|
|
|
|
|
|
|
Range of
|
|
|
|
remaining
|
|
|
|
|
|
|
|
|
|
|
|
contractual
|
|
|
|
Number of
|
|
|
|
$
|
|
|
|
life (years)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00
- 0.25
|
|
|
4,039,834
|
|
|
5.06
|
|
|
0.09
|
|
|
1,589,834
|
|
|
0.09
|
|
0.26
- 0.50
|
|
|
3,078,189
|
|
|
5.37
|
|
|
0.31
|
|
|
2,528,189
|
|
|
0.31
|
|
0.51
- 0.75
|
|
|
1,895,000
|
|
|
0.80
|
|
|
0.67
|
|
|
1,895,000
|
|
|
0.67
|
|
0.76
- 1.00
|
|
|
1,223,750
|
|
|
1.01
|
|
|
0.83
|
|
|
1,223,750
|
|
|
0.83
|
|
|
|
|
10,236,773
|
|
|
3.87
|
|
|
0.35
|
|
|
7,236,773
|
|
|
0.44
|
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Stock
Options and Warrants (continued)
Stock
Options (continued)
The
weighted average fair value of options granted for the three month periods
ended
September 30, 2008 and 2007 was $0.03 and nil, respectively, as summarized
below.
|
|
Number of options
|
|
Weighted average
exercise price
|
|
Weighted average grant-
date fair value
|
|
|
|
September 30
|
|
September 30
|
|
September 30
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
Options
granted during the year ended June 30, 2008 and 2007, exercise prices
equal to market price at time of grant
|
|
|
250,000
|
|
|
-
|
|
|
0.07
|
|
|
-
|
|
|
0.03
|
|
|
-
|
|
The
Company recognized stock-based compensation for employees and directors in
the
amount of $42,345 and $112,039 for the three month periods ended September
30,
2008 and 2007, respectively. The amount of stock based compensation for the
three months ended September 30, 2007 includes $64,684 for the departure of
the
president of AVI in July 2007.
The
fair
value of the options granted during the period was measured at the date of
grant
using the Black-Scholes option pricing model with the following weigthed-average
assumptions:
|
|
Three month periods
|
|
|
|
September 30,
|
|
|
|
2008
|
|
2007
|
|
Risk - free interest rate
|
|
|
1.96
|
%
|
|
-
|
|
Expected
volatility
|
|
|
100
|
%
|
|
-
|
|
Expected
life of stocks options (in years)
|
|
|
4.00
|
|
|
-
|
|
Assumed
dividends
|
|
|
None
|
|
|
-
|
|
As
at
September 30, 2008, the Company has $215,500 of total unrecognized stock-based
compensation expense related to non-vested stock options granted under the
Company’s stock option plan that it expects to recognize over a period of four
years (June 30, 2009 - $121,587, June 30, 2010 - $37,825, June 30, 2011 -
$37,108, June 30, 2012 - $18,891).
Options
for 50,000 Company common stock shares were exercised during the three months
ended September 30, 2008 at an exercise price of $0.00001, while zero stock
options were exercised during the year ended June 30, 2008. The impact to cash
receipts from the exercise of stock options is included in financing activities
in the accompanying consolidated statements of cash flows.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Stock
Options and Warrants (continued)
Warrants
outstanding as at September 30 and June 30, 2008
|
|
Outstanding
|
|
Warrant exercise
prices
|
|
Series E
|
|
|
1,803,333
|
|
|
0.31
|
|
Series
G
|
|
|
1,144,131
|
|
|
0.05
|
|
Series
H
|
|
|
890,593
|
|
|
0.35
|
|
Series
I
|
|
|
1,144,131
|
|
|
0.05
|
|
Series
J
|
|
|
1,781,184
|
|
|
0.50
|
|
Series
K
|
|
|
2,653,845
|
|
|
0.70
|
|
Series
P
|
|
|
8,091,403
|
|
|
0.11
|
|
Series
Q
|
|
|
20,276,190
|
|
|
0.11
|
|
Series
T
|
|
|
1,936,937
|
|
|
0.11
|
|
Series
W
|
|
|
711,492
|
|
|
0.35
|
|
Series
Y
|
|
|
162,794
|
|
|
0.11
|
|
Series
Z
|
|
|
2,441,873
|
|
|
0.11
|
|
IB-01
|
|
|
7,692
|
|
|
0.00001
|
|
IB-02
|
|
|
248,532
|
|
|
0.48
|
|
IB-03
|
|
|
374,171
|
|
|
0.53
|
|
IB-06
|
|
|
457,098
|
|
|
0.05
|
|
Total
|
|
|
44,125,399
|
|
|
0.18
|
|
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
15.
|
Commitments
and Contingencies
|
Commitments
Minimum
lease payments for the next five fiscal years are as follows:
|
|
$
|
|
2009
|
|
|
318,148
|
|
2010
|
|
|
270,810
|
|
2011
|
|
|
31,418
|
|
2012
|
|
|
1,982
|
|
2013
|
|
|
-
|
|
|
|
|
622,358
|
|
The
Company leases premises for its various offices located across Canada. Total
rent expense was $106,067 and $105,264 for the three month periods ended
September 30, 2008 and 2007, respectively.
Litigation
and Settlement Costs
On
February 7, 2007, a lawsuit was filed by a former employee in Superior Court
of
Quebec for a total amount of $256,819 (CAD $273,307), with regards to alleged
breach of employment contract and wrongful dismissal.
The
Company has filed its response, and is in the process of contesting the case
vigorously. Furthermore, a court date for the hearing has been
scheduled.
16.
|
Research
and Development Investment Tax
Credits
|
The
Company’s investment tax credit recovery for the three months ended September
30, 2008 was negatively affected as a result of revisions to amounts previously
estimated and recorded for credits related to the fiscal year ended June 30,
2007. As a result of these revisions, which relate to new information obtained
following the taxation authorities’ examination, the investment tax credit
recoveries pertaining to the year ended June 30, 2007 were determined to be
$59,057 less than expected. The resulting unfavorable adjustment to investment
tax credits receivable was recorded during the three months ended September
30,
2008. The Company includes investment tax credits arising from research and
development activities as part of the income tax provision for the period.
The
Company’s income tax provision for the three months ended September 30, 2008
includes only such tax credits, arising from research and development
activities. The investment tax credits recorded by the Company are subject
to
review and approval by taxation authorities and it is possible that the amounts
granted will be different from the amounts recorded by the Company.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
The
Company reports segment information in accordance with SFAS No. 131, “Disclosure
About Segments of an Enterprise and Related Information”. Reporting segments are
based upon the Company’s internal organization structure, the manner in which
the Company’s operations are managed, the criteria used by the Company’s chief
operating decision-maker to evaluate segment performance and the availability
of
separate financial information.
Commencing
on July 1, 2007, and as a result of changes in business operations, the
Company’s current structure is distributed among two reporting segments, Fiber
Technologies and Solutions, each with different product and service offerings.
The Fiber Technologies reporting segment is comprised of the operations of
Avensys Tech and ITF and provides fiber-based technologies and products. The
Solutions reporting segment is comprised of the operations of Avensys Solutions
and offers products and services to the environmental monitoring solutions
marketplace. The 2007 figures have been reclassified on this basis. The Company
has not disclosed revenues from each group of products or services, given that
it is impracticable to do so.
Direct
contribution consists of revenues less direct costs. Direct costs include
specific costs of net revenues, sales and marketing expenses, and general and
administrative expenses over which segment managers have direct discretionary
control, such as sales programs, customer support expenses, bank charges and
bad
debt write-offs. Expenses over which segment managers do not currently have
discretionary control, such as site operations costs, product development
expenses, and general and administrative costs, are monitored by corporate
management and are not evaluated in the measurement of segment performance.
Corporate management operating costs are primarily represented as part of ‘Other
operating expenses and indirect costs of net revenues’.
|
|
Fiber
Technologies
|
|
Solutions
|
|
Consolidated
|
|
Net revenues from external
customers
|
|
|
3,347,989
|
|
|
2,343,261
|
|
|
5,691,250
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of net revenues
|
|
|
2,512,656
|
|
|
1,417,405
|
|
|
3,930,061
|
|
Marketing
and sales expense
|
|
|
125,486
|
|
|
734,961
|
|
|
860,447
|
|
General
and administrative expense
|
|
|
338,343
|
|
|
279,479
|
|
|
617,822
|
|
Research
and development expense
|
|
|
396,782
|
|
|
-
|
|
|
396,782
|
|
Depreciation
and amortization expense
|
|
|
79,363
|
|
|
31,543
|
|
|
110,906
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
costs
|
|
|
3,452,630
|
|
|
2,463,389
|
|
|
5,916,019
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
contribution
|
|
|
(104,641
|
)
|
|
(120,128
|
)
|
|
(224,769
|
)
|
Other
operating expenses & indirect costs of net revenues
|
|
|
|
|
|
|
|
|
(412,265
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Loss
from Operations
|
|
|
|
|
|
|
|
|
(637,034
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense)
|
|
|
|
|
|
|
|
|
1,724
|
|
Loss
on redemption of convertible debentures
|
|
|
|
|
|
|
|
|
-
|
|
Interest
expense, net
|
|
|
|
|
|
|
|
|
(74,788
|
)
|
Debenture
accretion and change in fair value of derivative financial
instruments
|
|
|
|
|
|
|
|
|
29,568
|
|
Loss
on extinguishment of debt
|
|
|
|
|
|
|
|
|
(47,044
|
)
|
Income
Tax Benefit - Refundable tax credits (*)
|
|
|
|
|
|
|
|
|
157,752
|
|
Non-Controlling
Interest
|
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss from Continuing Operations
|
|
|
|
|
|
|
|
|
(569,840
|
)
|
(*) –
Relates entirely to the Research & Development activities of the Fiber
Technologies segment.
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Segment
Disclosure (continued)
For
the three month period ended September 30, 2007
|
|
Fiber
Technologies
|
|
Solutions
|
|
Consolidated
|
|
Net revenues from external customers
|
|
|
3,685,292
|
|
|
1,112,717
|
|
|
4,798,009
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of net revenues
|
|
|
2,069,524
|
|
|
679,868
|
|
|
2,749,392
|
|
Marketing
and sales expense
|
|
|
93,258
|
|
|
368,045
|
|
|
461,303
|
|
General
and administrative expense
|
|
|
163,227
|
|
|
110,847
|
|
|
274,074
|
|
Research
and development expense
|
|
|
464,311
|
|
|
-
|
|
|
464,311
|
|
Depreciation
and amortization expense
|
|
|
59,636
|
|
|
6,305
|
|
|
65,941
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
costs
|
|
|
2,849,956
|
|
|
1,165,065
|
|
|
4,015,021
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
contribution
|
|
|
835,336
|
|
|
(52,348
|
)
|
|
782,988
|
|
Other
operating expenses & indirect costs of net revenues
(+)
|
|
|
|
|
|
|
|
|
(971,582
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Loss
from Operations
|
|
|
|
|
|
|
|
|
(188,594
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense)
|
|
|
|
|
|
|
|
|
11,951
|
|
Loss
on redemption of convertible debentures
|
|
|
|
|
|
|
|
|
(1,422,577
|
)
|
Interest
expense, net
|
|
|
|
|
|
|
|
|
(308,980
|
)
|
Debenture
accretion and change in fair value of derivative financial
instruments
|
|
|
|
|
|
|
|
|
(498,365
|
)
|
Loss
on extinguishment of debt
|
|
|
|
|
|
|
|
|
-
|
|
Income
Tax Benefit - Refundable tax credits (*)
|
|
|
|
|
|
|
|
|
169,001
|
|
Non-Controlling
Interest
|
|
|
|
|
|
|
|
|
(139
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss from Continuing Operations
|
|
|
|
|
|
|
|
|
(2,237,703
|
)
|
(*)
-
Relates entirely to the Research & Development activities of the Fiber
Technologies segment.
(+)
-
Includes $212,000 of salary expense related to the departure of the President
of
AVI in July 2007.
Revenue
generated from two customers of the Company’s Fiber Technologies segment for the
years ended June 30, 2008 and 2007 was approximately as follows:
|
|
Three months ended September 30,
|
|
|
|
2008
|
|
2007
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Customer
1
|
|
|
816,464
|
|
|
2,468,983
|
|
Customer
2
|
|
|
1,156,332
|
|
|
477,139
|
|
|
|
|
1,972,796
|
|
|
2,946,122
|
|
The
outstanding receivable balances for these customers at September 30, 2008
amounted to $1,706,522 (Customer 1 represented $481,750 and Customer 2
represented $1,224,772).
Avensys
Corporation
Notes
to
Interim Consolidated Financial Statements
Unaudited
(Expressed
in U.S. Dollars)
September
30, 2008
Segment
Disclosure (continued)
The
Company’s assets are allocated as follows:
|
|
September 30,
|
|
June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
Fiber
Technologies
|
|
|
9,186,863
|
|
|
9,101,193
|
|
Solutions
|
|
|
4,018,908
|
|
|
3,977,932
|
|
All
Other (*)
|
|
|
7,653,925
|
|
|
8,261,349
|
|
|
|
|
20,859,696
|
|
|
21,340,474
|
|
(*)
includes Avensys Corp. assets (including goodwill and intangible assets
identified in the acquisition of Avensys Inc. during February 2005) which cannot
be allocated to either of the reporting segments.
The
Company has three geographic business areas, Americas, Europe and Asia,
determined based on the locations of the customers. The revenues for the three
months ended September 30, 2008 and 2007 for the Americas include approximately
$1,268,000 and $2,724,000, respectively, of sales to the United States of
America and $2,404,000 and $1,162,000, respectively, of sales to Canada. The
revenues for Asia for the three months ended September 30, 2008 and 2007 include
sales of $1,269,000 and $506,000, respectively, to China.
Geographic
Information
|
|
2008
|
|
2007
|
|
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
Americas
|
|
|
3,671,367
|
|
|
3,887,915
|
|
Europe
|
|
|
623,873
|
|
|
355,344
|
|
Asia
|
|
|
1,396,010
|
|
|
554,749
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
5,691,250
|
|
|
4,798,008
|
|
ITEM 2.
|
MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION
AND RESULTS OF OPERATIONS
|
This
management's discussion and analysis of financial condition and results of
operations of Avensys Corporation should be read in conjunction with the
financial statements and notes thereto of the Company for the three month
periods ended September 30, 2008 and 2007 as included in this Form
10-Q.
CORPORATE
OVERVIEW
Avensys
Corporation (“Avensys”) operates two divisions, through its wholly owned
subsidiary Avensys Inc.:
|
·
|
Avensys
Technologies designs, manufactures, distributes, and markets high
reliability optical components and modules as well as FBGs for the
telecom
market and high power devices and sub-assemblies for the industrial
market.
|
|
·
|
Avensys
Solutions, the other division of Avensys, is an industry leader in
providing instrumentation and integrated solutions for the monitoring
of
industrial processes and environmental surveillance applications
for air,
water and soil in the Canadian marketplace.
|
For
the
three month period ended September 30, 2008, Avensys’ revenues were $5.7
million, compared to $4.8 million for the same period last year. Revenues for
the three month period were 18.6% ahead of revenues for the same period last
year. Avensys’ loss from operations for the three month period was $637,000,
compared to a loss from operations of $189,000 for the same period last year.
The gross margin of $1.8 million for the quarter was 30.9% as a percentage
of
sales compared with $2.0 million and 42.7% a year earlier.
Net
cash
used in operating activities from continuing operations during the three month
period ended September 30, 2008, totaled $854,000, as compared with net cash
used of 538,000 for the same period last year.
Net
loss
for the three month period ended September 30, 2008 was $570,000, compared
with
$2.1 million for the same period a year earlier.
Avensys
Tech Division of Avensys Inc.
Avensys
Tech sells its optical products and services primarily in North America, Asia,
and Europe to the telecommunications, fiber laser, and sensors industries.
It
currently operates in three vertical markets within the photonics industry:
the
telecommunications market, the growing fiber laser market, and, the fiber sensor
market.
The
telecom segment represents about 72% of our optical sales. Fiber laser
components and modules and optical sensors comprise the remaining 28% of optical
sales. Our traditional terrestrial telecom components and fiber laser
components, developed by our R&D partner ITF labs, saw important growth,
while DPSK demodulators (“Differential Phase Shift Keying”) and undersea telecom
components had a major role in the overall reduction in revenues at Avensys
Tech. We received smaller than usual orders for undersea telecom components
during the first quarter. On another note, Avensys Tech has surpassed the mark
of 42,614 Fiber Bragg Gratings (FBG) units shipped during the first quarter
of
fiscal 2009. This milestone was achieved through a steady growth in the monthly
production of FBG’s and represents an increase of 199% compared to 14,268 units
shipped during the same period last year.
Our
DPSK
product is now adopted by the telecom industry. Consequently, we expect
substantial volume growth in the next years but also a pressure on cost
reduction. To face this challenge ITF Labs, our R&D partner, undertook a
major R&D project two years ago to design the new generation of our
demodulators, the micro-DPSK. On February 20, 2008, ITF Labs announced the
R&D completion of its micro-DPSK. This device is designed small enough to be
incorporated into the industry standard 300-pin Multi-Source Agreement (MSA)
compliant transponder package, and will be available with bitrates for 40Gb/s
DPSK and DQPSK with free-spectral-range from 20 GHz to 70GHz. The device has
the
lowest loss and highest extinction ratio on the market with an almost
insignificant polarization dependency of less than 1.5% of free-spectral range.
All dimensions of the device have been reduced, making this the thinnest,
fastest tuning, lowest power consumption product available on the market which
enables the integration of either DPSK or DQPSK formats into the MSA package.
Many
Tier
1 and Tier 2 companies are currently developing their own platforms. So far,
we
have distributed demonstration micro-DPSKs and the reception is encouraging.
We
recently received the first purchase order for 40 units for some beta
productions. The majority of our customers are targeting to start their
production in January 2009.
Finally,
the micro-DPSK design allows significant cost reduction and high manufacturing
yield, two key parameters to win the business on competitiveness side. ITF
Labs
anticipates transferring the production of its micro-DPSK to Avensys Tech in
the
second quarter of 2009.
Three
major fiber laser providers have chosen to incorporate our technology into
their
product lines. Optical sensors remain part of our long term strategy, although
the current growth of this market segment is still limited to the single digit
range. Recently, our partner, ITF Labs has won another overseas military
contract to build leading edge high power fiber laser components and systems.
The
demonstration of above kilowatt operation of our fiber laser components as
well
as our successes with DPSK demodulator modules and sensors constitute three
areas where we see new sources of revenue that are clearly part of our long
term
path to success. In addition, the undersea telecom market has been rich in
new
initiatives with recent announcement for various long haul systems. Avensys
Tech, as one of the few components companies in the world with undersea
certified production lines, is often an indirect beneficiary of such large
scale
projects.
The
Avensys Solutions Division of Avensys Inc.
Avensys
Solutions competes in the Canadian marketplace providing instrumentation and
integrated systems capable of detecting and quantifying the presence of specific
pollutants, gases and other components in ambient air, stack emissions, waste
water, natural water sources and soil. It also addresses the monitoring needs
of
industrial processes for the purpose of surveillance and optimization.
The
market for these solutions in Canada is quite mature, with specific areas
growing faster due to increased regulation, pressures on reducing Greenhouse
gas
emissions and emerging opportunities associated with carbon credit trading.
We
continue to be firm believers in this exciting business segment that has allowed
us, through its stability, to be a more solid organization.
We
anticipate that this market will experience overall growth and consolidation
as
the private and public sectors recognize the value of sustainable development
and environmentally responsible behavior. Following the acquisition of
operations of Willer Engineering on March 28, 2008, we completed the integration
of the teams, including territory coverage optimization, and product
cross-training. We have also focused on achieving the expected economies of
scale related to overhead expenses, including the adaption of our eQRP systems
to encompass Willer’s business activities, the rationalization of combined
promotional efforts and marketing tools, the streamlining of our finance and
accounting processes.
We
have
harmonized our processes and successfully undergone ISO re-certification, a
key
requirement to qualify has a vendor in several of our markets.
Our
Systems Integration teams has doubled in size and was successful in booking
orders approaching $1.8M, with the majority of these orders deliverables within
the first two quarters of the fiscal year. This is, for the most part,
attributable to our industrial customer base, a segment where complex
applications often require the integration of several technologies into a
turn-key solution.
The
portion of our revenues stemming from our traditional environmental business
has
remained relatively stable despite the downward pressure on market prices
resulting from the strength of the Canadian dollar. Overall, Avensys Solutions
revenues for the quarter ended September 30, 2008 have grown by 110.6% over
the
same quarter in previous year, a significant portion of this growth being
attributable to the acquisition of Willer Engineering’s assets.
RESULTS
OF OPERATIONS FOR THE THREE MONTH PERIOD ENDED SEPTEMBER 30, 2008 COMPARED
TO
THE THREE MONTH PERIOD ENDED SEPTEMBER 30, 2007
The
results of operations include the accounts of the Company and its
subsidiaries.
|
|
Three Months Ended September 30,
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
Revenue
|
|
|
5,691,250
|
|
|
4,798,008
|
|
|
893,242
|
|
|
18.6
|
%
|
Cost
of Revenue
|
|
|
3,930,061
|
|
|
2,749,392
|
|
|
1,180,669
|
|
|
42.9
|
%
|
Gross
margin
|
|
|
1,761,189
|
|
|
2,048,616
|
|
|
(287,427
|
)
|
|
-14.0
|
%
|
Gross
Margin as % of Revenue
|
|
|
30.9
|
%
|
|
42.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
231,282
|
|
|
208,891
|
|
|
22,391
|
|
|
10.7
|
%
|
Selling,
general and administration
|
|
|
1,770,159
|
|
|
1,564,008
|
|
|
206,151
|
|
|
13.2
|
%
|
Research
and development
|
|
|
396,782
|
|
|
464,311
|
|
|
(67,529
|
)
|
|
-14.5
|
%
|
Total
Operating expenses
|
|
|
2,398,223
|
|
|
2,237,210
|
|
|
161,013
|
|
|
7.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
(loss) gain
|
|
|
(637,034
|
)
|
|
(188,594
|
)
|
|
(448,440
|
)
|
|
237.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expenses)
|
|
|
(90,540
|
)
|
|
(2,217,971
|
)
|
|
2,127,431
|
|
|
-95.9
|
%
|
Income
tax benefits - refundable tax credits
|
|
|
157,752
|
|
|
169,001
|
|
|
(11,249
|
)
|
|
-6.7
|
%
|
Non-Controlling
interest
|
|
|
(18
|
)
|
|
(139
|
)
|
|
121
|
|
|
-87.1
|
%
|
Results
of discontinued operations
|
|
|
-
|
|
|
95,851
|
|
|
(95,851
|
)
|
|
-100.0
|
%
|
Net
(loss) income for the period
|
|
|
(569,840
|
)
|
|
(2,141,852
|
)
|
|
1,572,012
|
|
|
-73.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation adjustments
|
|
|
(436,031
|
)
|
|
781,187
|
|
|
(1,217,218
|
)
|
|
|
|
Comprehensive
income
|
|
|
(1,005,871
|
)
|
|
(1,360,665
|
)
|
|
354,794
|
|
|
-26.1
|
%
|
Revenue
Sales
from the Avensys Tech and Avensys Solutions divisions of Avensys Inc., for
the
three month period ended September 30, 2008, account for 100% of our net
revenues. Avensys products were sold directly to customers throughout the world.
Our
revenues were composed of the following:
|
|
Three Months Ended September 30,
|
|
|
|
|
|
|
|
2008
|
|
% of
Revenue
|
|
2007
|
|
% of
Revenue
|
|
Change
|
|
Change
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
%
|
|
Avensys
Tech
|
|
|
3,347,989
|
|
|
59
|
%
|
|
3,685,292
|
|
|
77
|
%
|
|
(337,303
|
)
|
|
-9.2
|
%
|
Avensys
Solutions
|
|
|
2,343,261
|
|
|
41
|
%
|
|
1,112,717
|
|
|
23
|
%
|
|
1,230,544
|
|
|
110.6
|
%
|
Revenue
|
|
|
5,691,250
|
|
|
|
|
|
4,798,009
|
|
|
|
|
|
893,241
|
|
|
18.6
|
%
|
Our
revenues for the three month period ended September 30, 2008 increased by 18.6%,
over the same period in the previous year. The three month increase is primarily
due to the Willer acquisition, contributing to a 110.6% increase in revenues
at
the Avensys Solutions division. Avensys Tech saw its revenue decrease by 9.2%
primarily due to reduced order sizes for undersea telecom components during
the
three months ended September 30, 2008.
Cost
of revenue and gross margin
Cost
of
goods sold as a percentage of revenue was 69.1% for the three month period
ended
September 30, 2008 compared with 57.3% for the same period in the previous
year.
Gross margin, relative to revenues, for the three month period ended September
30, 2008 decreased as a result of decreasing margins at Avensys Tech. Avensys
Tech saw increases in the costs of production, for three months ended September
30, 2008, primarily due to significantly increased sales of lower margin
products.
Operating
Expenses
Depreciation
and amortization
Depreciation
and amortization expenses for the three month period ended September 30, 2008
increased by $22,391 over the same period in 2007. Avensys continues to invest
in production equipment to keep pace with the significant increases in
revenues.
Selling
General and Administrative expenses
Selling,
general and administrative (SG&A) expenses consisted primarily of general
and administrative expenses, marketing and sales expenses, payroll and related
expenses, and professional fees. SG&A expenses for the three month period
ended September 30, 2008 increased by $206,151 compared to the same period
in
2007. SG&A are composed of the following:
|
|
Three Months Ended September 30,
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
General
and administrative
|
|
|
192,397
|
|
|
93,846
|
|
|
98,551
|
|
|
105.0
|
%
|
Marketing
and Sales
|
|
|
185,552
|
|
|
109,694
|
|
|
75,858
|
|
|
69.2
|
%
|
Payroll
and related expenses
|
|
|
1,141,768
|
|
|
1,109,112
|
|
|
32,656
|
|
|
2.9
|
%
|
Professional
fees
|
|
|
231,227
|
|
|
227,820
|
|
|
3,407
|
|
|
1.5
|
%
|
Travel
|
|
|
17,916
|
|
|
22,760
|
|
|
(4,844
|
)
|
|
-21.3
|
%
|
Other
|
|
|
1,300
|
|
|
776
|
|
|
524
|
|
|
67.5
|
%
|
Selling,
General and Administrative Expenses
|
|
$
|
1,770,160
|
|
$
|
1,564,008
|
|
$
|
206,152
|
|
|
13.2
|
%
|
General
and administrative expenses and Marketing and sales expenses for the three
month
period ended September 30, 2008 increased compared with the same periods in
the
previous year primarily due to the addition of the operations acquired in the
Willer transaction.
Research
and Development
For
the
three months ended September 30, 2008, research and development expenses
primarily consisted of salaries and related expenses for research personnel,
prototype manufacturing and testing at the ITF Labs facility in Montreal,
Quebec.
Research
and development expenses for the three month period ended September 30, 2008
decreased by $67,529 compared with the same period in 2007. The three month
period decrease is primarily attributable to a reduction in process optimization
research compared to the previous year at ITF Labs.
Stock
Based Compensation
Stock
based compensation, which is included in ‘Other selling, general and
administrative’ expenses, for the three month period ended September 30, 2008,
was $42,345 compared to $112,039 for the same period last year. The decreases
in
stock based compensation expenses are primarily attributed to the decrease
in
the quantities and calculated fair values of employee stock options issued
during the year ended June 30, 2008. The fair value of the employee stock
options is determined using the Black-Scholes Model and the expenses are
recorded evenly over the vesting period on each stock option
grant.
Other
Income (Expenses)
Other
income (expenses) consists of the following:
|
|
Three Months Ended September 30,
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
Other
income (expenses), net
|
|
|
1,724
|
|
|
11,951
|
|
|
(10,227
|
)
|
|
-85.6
|
%
|
Loss
on redemption of convertible debentures
|
|
|
-
|
|
|
(1,422,577
|
)
|
|
1,422,577
|
|
|
-100.0
|
%
|
Interest
expense, net
|
|
|
(74,788
|
)
|
|
(308,980
|
)
|
|
234,192
|
|
|
-75.8
|
%
|
Debentures
and balance of purchase price accretion
|
|
|
(302,568
|
)
|
|
(226,536
|
)
|
|
(76,032
|
)
|
|
33.6
|
%
|
Loss
on extinguishment of debt
|
|
|
(47,044
|
)
|
|
-
|
|
|
(47,044
|
)
|
|
N/A
|
|
Change
in fair value of derivative financial instruments
|
|
|
332,136
|
|
|
(271,829
|
)
|
|
603,965
|
|
|
-222.2
|
%
|
Other
income (expenses)
|
|
$
|
(90,540
|
)
|
$
|
(2,217,971
|
)
|
$
|
2,127,431
|
|
|
-95.9
|
%
|
Refundable
Tax Credits
Refundable
tax credits for the three month period ended September 30, 2008, decreased
by
$11,249, compared with the same period in 2007. The Company includes investment
tax credits arising from research and development activities as part of the
income tax provision for the year. The Company’s income tax provision for the
three month period ended September 30, 2008 includes only such tax credits,
arising from research and development activities. The Company’s investment tax
credit recovery for the three months ended September 30, 2008 was negatively
affected as a result of revisions to amounts previously estimated and recorded
for credits related to the fiscal year ended June 30, 2007. As a result of
these
revisions, which relate to new information obtained following the taxation
authorities’ examination, the investment tax credit recoveries pertaining to the
year ended June 30, 2007 were determined to be $59,057 less than expected.
The
resulting unfavorable adjustment to investment tax credits receivable was
recorded during the three months ended September 30, 2008. The Company includes
investment tax credits arising from research and development activities as
part
of the income tax provision for the period. The Company’s income tax provision
for the three months ended September 30, 2008 includes only such tax credits,
arising from research and development activities. The investment tax credits
recorded by the Company are subject to review and approval by taxation
authorities and it is possible that the amounts granted will be different from
the amounts recorded by the Company.
Division
Direct Contribution
Division
direct contribution consists of division revenues less division direct costs.
Direct costs include specific costs of net revenues, sales and marketing
expenses, and general and administrative expenses over which division managers
have direct discretionary control, such as sales programs, customer support
expenses, bank charges and bad debt write-offs. Changes in direct contribution
for the Avensys Tech and Avensys Solutions divisions are outlined, as
follows:
|
|
Avensys Tech
|
|
|
|
Three Months Ended September 30,
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
Net
revenues from external customers
|
|
|
3,347,989
|
|
|
3,685,292
|
|
|
(337,303
|
)
|
|
-9.15
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of net revenues
|
|
|
2,512,656
|
|
|
2,069,524
|
|
|
443,132
|
|
|
21.41
|
%
|
Marketing
and sales expense
|
|
|
125,486
|
|
|
93,258
|
|
|
32,228
|
|
|
34.56
|
%
|
General
and administrative expense
|
|
|
338,343
|
|
|
163,227
|
|
|
175,116
|
|
|
107.28
|
%
|
Research
and development expense
|
|
|
396,782
|
|
|
464,311
|
|
|
(67,529
|
)
|
|
-14.54
|
%
|
Depreciation
and amortization expense
|
|
|
79,363
|
|
|
59,636
|
|
|
19,727
|
|
|
33.08
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
costs
|
|
|
3,452,630
|
|
|
2,849,956
|
|
|
602,674
|
|
|
21.15
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
contribution
|
|
|
(104,641
|
)
|
|
835,336
|
|
|
(939,977
|
)
|
|
-112.53
|
%
|
Direct
costs for the Avensys Tech division increased 21.1% for the three month period
ended September 30, 2008, over the same period in the previous year, primarily
due to increased marketing and sales and general and administrative
expenses.
|
|
Avensys Solutions
|
|
|
|
Three Months Ended September 30,
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
Net
revenues from external customers
|
|
|
2,343,261
|
|
|
1,112,717
|
|
|
1,230,544
|
|
|
110.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of net revenues
|
|
|
1,417,405
|
|
|
679,868
|
|
|
737,537
|
|
|
108.5
|
%
|
Marketing
and sales expense
|
|
|
734,961
|
|
|
368,045
|
|
|
366,916
|
|
|
99.7
|
%
|
General
and administrative expense
|
|
|
279,479
|
|
|
110,847
|
|
|
168,632
|
|
|
152.1
|
%
|
Research
and development expense
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.0
|
%
|
Depreciation
and amortization expense
|
|
|
31,544
|
|
|
6,305
|
|
|
25,239
|
|
|
400.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
costs
|
|
|
2,463,389
|
|
|
1,165,065
|
|
|
1,298,324
|
|
|
111.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
contribution
|
|
|
(120,128
|
)
|
|
(52,348
|
)
|
|
(67,780
|
)
|
|
129.5
|
%
|
Direct
costs for the Avensys Solutions division increased 111.4% for the three month
period ended September 30, 2008, over the same period in the previous year.
The
growth in direct costs is highlighted by an increase in general and
administrative expenses associated with the administrative salaries from the
Willer acquisition and increased training costs.
Net
Loss
Our
net
loss of $569,840 for the three month period ended September 30, 2008 represents
an improvement of $1,667,863 compared to the net loss of $2,237,210 for the
same
period in 2007. This improvement primarily resulted from the loss of $1,422,577
on redemption of convertible debentures for the three month period ended
September 30, 2007, compared to zero for the same period in 2008; offset by
a
$287,427 reduction in gross profit and a $161,013 increase in operating
expenses.for the three month period ended September 30, 2008, compared to the
same period last year.
We
incurred liabilities that are treated as derivative financial instruments as
part of our acquisition of ITF Optical assets, the August 2006 (First Tranche)
and November 2006 (Second Tranche) financing ("derivative liabilities") and
the
Senior Secured OID Convertible Note issued in September 2007. These derivative
liabilities are re-evaluated at each period end using the Black-Scholes option
pricing model, and are, consequently, sensitive to changes in the market price
of our own shares. Due to this expanded use of derivative financial instruments,
the volatility of our results of operations has increased considerably, as
they
are increasingly affected by fluctuations in the fair value of our shares.
At
September 30, 2008 and 2007, our share price was $0.06 and $0.095 a share,
respectively, which impacted the fair values of the derivative liabilities
on
our balance sheet at those dates and reduced our net loss for the three month
period ended September 30, 2008 by $332,136 and increased our net loss for
the
three month period ended September 30, 2007 by $271,829.
Financial
Condition, Liquidity and Capital Resources
As
discussed in Note 1 to the financial statements the Company’s operating
subsidiary, Avensys Inc., maintains a line of credit from a financial
institution, and the covenants pertaining to such were not respected as at
September 30, 2008. This constitutes an event of default and could result in
the
financial institution requiring repayment of a loan. The failed covenants with
the financial institution triggered cross-default clauses affecting the
Company’s Working Capital Facility and Senior Secured Convertible Debenture. The
Company has obtained waivers with respect to such cross-default clauses for
the
Working Capital Facility and Senior Secured Convertible Debenture. Avensys
Inc.
is seeking to renegotiate the credit agreement with the financial institution
and is also seeking to obtain additional conventional bank credit-line financing
to that which it already has, to support its growing operations. The material
uncertainties resulting from the above events and conditions are such that
there
exists substantial doubt that the Company would be able to continue as a going
concern at September 30, 2008. The Company’s continuation as a going concern is
dependent upon the continued support of shareholders, lenders and suppliers
and
its ability to obtain additional cash to allow for the satisfaction of its
obligations on a timely basis.
During
the first quarter of fiscal 2009, as described in Note 8 to the financial
statements, the Company amended an agreement with the former shareholders of
ITF
Optical Technologies. The amendment postponed, by 18 months, the exercise date
of a put option that could have required the cash outlay of CAD $2,000,000
between April and October 2009.
Historically,
our operations have been financed primarily from cash on hand, from the sale
of
common shares or the sale of convertible debentures. The operations of our
subsidiary Avensys Inc. have been supported primarily from revenue from the
sales of its products and services.
As
at
September 30, 2008, net working capital decreased to $289,080, compared to
net
working capital of $700,503 at June 30, 2008. Included in these figures for
net
working capital:
|
|
September 30,
|
|
June 30,
|
|
|
|
|
|
|
|
2008
|
|
2008
|
|
Change
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
%
|
|
Cash,
cash equivalents, and short term investments
|
|
|
202,646
|
|
|
369,396
|
|
|
(166,750
|
)
|
|
-45
|
%
|
Receivables
|
|
|
7,232,302
|
|
|
7,045,825
|
|
|
186,477
|
|
|
3
|
%
|
Inventory
|
|
|
2,310,780
|
|
|
2,178,686
|
|
|
132,094
|
|
|
6
|
%
|
Other
current assets
|
|
|
243,826
|
|
|
243,409
|
|
|
417
|
|
|
0
|
%
|
Current
assets
|
|
|
9,989,554
|
|
|
9,837,316
|
|
|
152,238
|
|
|
2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued liabilities
|
|
|
6,130,423
|
|
|
6,401,379
|
|
|
(270,956
|
)
|
|
-4
|
%
|
Loans
payable
|
|
|
3,394,371
|
|
|
2,554,371
|
|
|
840,000
|
|
|
33
|
%
|
Other
current liabilities
|
|
|
175,680
|
|
|
181,063
|
|
|
(5,383
|
)
|
|
-3
|
%
|
Current
Liabilities
|
|
|
9,700,474
|
|
|
9,136,813
|
|
|
563,661
|
|
|
6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
working capital
|
|
|
289,080
|
|
|
700,503
|
|
|
(411,423
|
)
|
|
-59
|
%
|
During
the three month period ended September 30, 2008, the Company, having produced
a
net loss of $569,840, used $854,281 of cash to fund Operating Activities from
continuing operations. Excluding working capital items, the Company used $32,970
of cash to fund Operating Activities from continuing operations. During the
three month period ended September 30, 2007, the Company, having produced a
net
loss of $2,141,852, used $537,768 of cash to fund Operating Activities from
continuing operations. Excluding working capital items, the Company generated
$171,966 of cash to fund Operating Activities from continuing
operations.
An
analysis of the three month periods is as follows:
|
|
Three Months Ended September 30,
|
|
|
|
|
|
2008
|
|
2007
|
|
Change
|
|
|
|
$
|
|
$
|
|
$
|
|
Net
(loss) income
|
|
|
(569,840
|
)
|
|
(2,141,852
|
)
|
|
1,572,012
|
|
Net
adjustments to reconcile net profit (loss) to cash generated by
(used in)
operating activities
|
|
|
536,870
|
|
|
2,313,818
|
|
|
(1,776,948
|
)
|
|
|
|
(32,970
|
)
|
|
171,966
|
|
|
(204,936
|
)
|
Change
in accounts receivable and other receivables
|
|
|
(431,877
|
)
|
|
119,892
|
|
|
(551,769
|
)
|
Change
in accounts payable and accrued liabilities
|
|
|
23,415
|
|
|
(584,897
|
)
|
|
608,312
|
|
Change
in other current assets and current liabilities
|
|
|
(412,849
|
)
|
|
(244,729
|
)
|
|
(168,120
|
)
|
Net
cash generated by (used in) operating activities from continuing
operations
|
|
$
|
(854,281
|
)
|
$
|
(537,768
|
)
|
|
(316,513
|
)
|
During
the three month period ended September 30, 2008, we mainly financed our
operations through the Senior Secured Working Capital Notes and the cash flows
generated by Avensys through the sales of products and services.
Selected
Balance Sheet information:
|
|
As of September 30,
|
|
As of June 30,
|
|
|
|
2008
|
|
2008
|
|
|
|
$
|
|
$
|
|
Total
Assets
|
|
|
20,859,696
|
|
|
21,340,474
|
|
Current
Liabilities
|
|
|
9,700,474
|
|
|
9,136,813
|
|
Long-Term
Liabilities
|
|
|
4,480,060
|
|
|
4,560,670
|
|
Non-Controlling
Interest
|
|
|
7,374
|
|
|
7,677
|
|
Total
Stockholder's Equity
|
|
|
6,671,788
|
|
|
7,635,314
|
|
The
480,778 decrease in total assets is attributable to decreases in long-lived
assets due to depreciation and amortization and the impact of foreign currency
translation, offset by increases in accounts receivable and inventories. The
$563,661 increase in current liabilities is mainly attributable to an increase
in bank and other loans payable, offset by a decrease in accounts payable and
accrued liabilities. The decrease in in long-term liabilities is primarily
attributable to the debt extinguishment and revaluation of the balance of
purchase price payable described in Note 8 to the financial statements, offset
by increases in convertible debentures due to accretion.
As
of
September 30, 2008, the Company had 99,086,152 issued and outstanding shares
compared to 99,036,152 on June 30, 2008. The increase in common shares is due
to
the issuance of 50,000 common shares in connection with the exercise of stock
options under the Company’s nonqualified employee stock option
plan.
Stock
options outstanding at September 30, 2008 totaled 10,236,773 at a weighted
average exercise price of $0.35 and have a weighted average remaining
contractual life of 3.87 years. Stock options outstanding at June 30, 2008
totaled 10,036,773 at a weighted average exercise price of $0.35 and had a
weighted average remaining contractual life of 4.05 years.
Senior
Secured OID convertible Debentures
During
the first quarter of fiscal 2008, the Company redeemed its Series B Subordinated
Secured Convertible Promissory Notes and its Original Issue Discount Series
B
Subordinated Secured Convertible Promissory Notes, both originally due February
11, 2009 (collectively the “Notes”). Under an arrangement with a majority of the
holders of the Notes, the Company also redeemed half of the associated Series
Y
and Series Z Warrants (collectively the “Warrants”) previously issued in August
2006 and November 2006 relating to the redeemed Notes. The total purchase price
for the redemption of the Notes and half of the Warrants was $3.4 million.
The
remaining half of the Warrants that are retained by the holders of the Notes
will have their exercise prices reduced to and fixed at $0.11 per share, with
no
further ratchet or anti-dilution provisions.
In
connection with the redemption of the Notes, the Company recorded a non-cash
charge of $1,422,577 in the first quarter of fiscal 2008 which is included
as
part of Other Expenses in the Statement of Operations and Comprehensive
Loss.
As
a
result of the redemption of the Notes, the security relating to the Notes has
been released.
In
connection with the redemption of the Notes, the Company received a $3.4 million
secured loan facility from Imperium Master Fund, LTD (the “Investor”). The terms
of the loan facility state that interest will be paid by the Company on the
unpaid principal amount at an annual rate equal to 8.5%. It was the intention
of
the Company and the Investor to replace the secured loan facility with a
comprehensive refinancing to facilitate a capital restructuring that would
provide the Company with additional working capital and credit facilities.
On
September 24, 2007, the Company entered into a Securities Purchase and Loan
Agreement (“SPL Agreement”) with the Investor for the sale of a 6% Original
Issue Discount Senior Secured Convertible Note (“Convertible Note”) in the
amount of $4,708,900. The principal value and the gross proceeds of the
Convertible Note is $4,000,000. The gross proceeds were used to repay the
secured loan facility of $3.4 million, with the balance of funds, $0.6 million,
for the Company’s working capital purposes.
The
Convertible Note matures on September 24, 2012 and the original principal amount
is convertible into common shares of the Company at a conversion price of $0.11.
The principal value will accrete to the value of the Convertible Note over
a
two-year period and will subsequently accrue interest at 6%. Monthly
installments of principal and interest will be payable commencing after the
second year up to the maturity date. The SPL Agreement also provides the holder
of the Convertible Note with Series Q warrants to purchase, subject to
adjustment, 20,276,190 shares of the Company’s outstanding common stock on a
fully diluted basis. On August 22, 2007, the Company issued to the holder of
the
Convertible Note Series P warrants, representing compensation for advisory
services rendered to the Company, to purchase up to 5% of the Company’s
outstanding common stock, initially amounting to 8,091,403 shares and subject
to
adjustment, on a fully diluted basis. In addition, the SPL Agreement provides
the Company with a $2,500,000 Working Capital Facility.
In
connection with this financing, specifically the shares to be received upon
potential conversion of the Convertible Note and the exercise of the Warrants,
the Company was obligated to file a registration statement with the Securities
and Exchange Commission (“SEC”). The registration statement was filed with the
SEC and became effective as of January 14, 2008.
To
secure
payment of the principal amount of the Convertible Note, the Company
hypothecated, in favor of the holder of the Convertible Note, the universality
of all of the immoveable and moveable assets, corporeal and incorporeal, present
and future of the Company.
The
Convertible Note contains events of default that would permit the Investor
to
demand repayment. At September 30, 2008, certain failed covenants with a
financial institution triggered a cross-default clause within the Convertible
Note. However, the Company has obtained waivers with respect to the
cross-default clause for the Working Senior Secured Convertible
Debenture.
The
SPL
with respect to this Convertible Note contains certain covenants (a) related
to
the conduct of the business of the Company and its subsidiaries; (b) related
to
certain financial covenants; (c) related to creation or assumption of liens
other than liens created pursuant to the SPL, as defined in the SPL; (d) for
so
long as this Note remains outstanding, the Company shall not, without the
consent of the holder of the Convertible Note, create, incur, guarantee, issue,
assume or in any manner become liable in respect of any indebtedness, other
than
permitted indebtedness, or issue other securities that rank senior to this
Convertible Note provided however that the Company could have a certain maximum
amount of outstanding bank debt.
Critical
Accounting Policies and Estimates
The
accompanying management discussion and analysis of our results of operations
and
financial condition are based on our consolidated financial statements, which
are prepared in accordance with accounting principles generally accepted in
the
United States of America (U.S. GAAP). The preparation of financial statements
in
conformity with United States Generally Accepted Accounting Principles requires
management to make estimates and assumptions that affect the reported amount
of
assets and liabilities and disclosure of contingent assets and liabilities
at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates. Our management routinely makes estimates about the effects of matters
that are inherently uncertain. These estimates form the basis for making
judgments about the financial position and results of operations, which are
integral to understanding the Company’s financial statements. We base our
estimates and judgments on historical experience and on other assumptions that
we believe are reasonable under the circumstances. However, future events cannot
be forecasted with certainty and the best estimates and judgments routinely
require adjustments. We are required to make estimates and judgments in many
areas, including those related to fair value of derivative financial
instruments, recording of various accruals, bad debts and inventory reserves,
the useful lives of long-lived assets such as property and equipment, warranty
obligations and potential losses from contingencies and litigation. We believe
the policies disclosed are the most critical to our financial statements because
their application places the most significant demands on management’s judgment.
Senior management has discussed the development, selection and disclosure of
these estimates with the Audit Committee of our Board of Directors.
There
have been no significant changes during the first quarter of fiscal year 2009
to
the items that we disclosed as our critical accounting policies and estimates
in
our discussion and analysis of financial condition and results of operations
in
our Form 10-K for the fiscal year ended June 30, 2008, Other than for elements
described in Recent Accounting Pronouncements below.
Recent
Accounting Pronouncements
In
February 2007, FASB issued SFAS No.159, “The Fair Value Option for Financial
Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 permits companies the
option, at specified election dates, to measure financial assets and liabilities
at their current fair value, with the corresponding changes in fair value from
period to period recognized in the income statement. Additionally, SFAS 159
establishes presentation and disclosure requirements designated to facilitate
comparisons between companies that choose different measurement attributes
for
similar assets and liabilities. SFAS 159 is effective as of the beginning of
the
first fiscal year that begins after November 15, 2007. The Company adopted
the
provisions of SFAS 159 beginning on July 1, 2008. The adoption of this standard
did not have a significant impact on the consolidated financial position and
results of operations of the Company.
In
March
2008, FASB issued FASB Statement No. 161, “Disclosures about Derivative
Instruments and Hedging Activities” (“SFAS 161”). SFAS 161 requires disclosure
of the fair values of derivative instruments and their gains and losses in
a
tabular format. It also requires disclosure of additional information about
an
entity’s liquidity by requiring disclosure of derivative features that are
credit risk-related. Finally, it requires cross-referencing within footnotes
to
enable financial statement users to locate important information about
derivative instruments. SFAS 161 is effective for financial statements issued
for fiscal years and interim periods beginning after November 15, 2008. Earlier
adoption is permitted. The Company adopted the provisions of SFAS 161 beginning
on July 1, 2008 and presents the fair values and gains and losses of derivative
instruments in Note 9 to the financial statements.
The
following represent recent accounting pronouncements not yet adopted that have
not been previously discussed in the notes to the audited financial statements
of June 30, 2008 or for which the Company is updating its description of
evaluation of impact.
a)
|
In
December 2007, FASB issued SFAS No. 160, “Non-controlling Interests in
Consolidated Financial Statements - an amendment of ARB No. 51” (“SFAS
160”). SFAS 160 establishes new accounting and reporting standards for
the
non-controlling interest in a subsidiary and for the deconsolidation
of a
subsidiary. Specifically, SFAS 160 requires the recognition of a
non-controlling interest (minority interest) as equity in the consolidated
financial statements and separate from the parent’s equity. The amount of
net income attributable to the non-controlling interest will be included
in consolidated net income on the face of the income statement. SFAS
160
clarifies that changes in a parent’s ownership interest in a subsidiary
that do not result in deconsolidation are equity transactions if
the
parent retains its controlling financial interest. In addition, SFAS
160
requires that a parent recognize a gain or loss in net income when
a
subsidiary is deconsolidated. Such gain or loss will be measured
using the
fair value of the non-controlling equity investment on the deconsolidation
date. SFAS 160 also includes expanded disclosure requirements regarding
the interests of the parents and its non-controlling interest. SFAS
is
effective for fiscal years, and interim periods within those fiscal
years,
beginning on or after December 15, 2008. Earlier adoption is prohibited.
The Company intends to adopt to adopt SFAS 160 effective January
1, 2009
and is currently evaluating the impact of the adoption of the provisions
of SFAS 160 on its consolidated financial
statements.
|
b)
|
In
April 2008, FASB issued FASB Staff Position (FSP) FAS 142-3,
“Determination of the Useful Life of Intangible Assets,” to provide
guidance for determining the useful life of recognized intangible
assets
and to improve consistency between the period of expected cash flows
used
to measure the fair value of a recognized intangible asset and the
useful
life of the intangible asset as determined under Statement 142. The
FSP
requires that an entity consider its own historical experience in
renewing
or extending similar arrangements. However, the entity must adjust
that
experience based on entity-specific factors under FASB Statement
142,
Goodwill and Other Intangible Assets. FSP FAS 142-3 is effective
for
fiscal years and interim periods that begin after November 15, 2008.
The
Company intends to adopt FSP FAS 142-3 effective January 1, 2009
and to
apply its provisions prospectively to recognized intangible assets
acquired after that date.
|
c)
|
In
June 2008, FASB ratified a consensus opinion reached by the Emerging
Issues Task Force (EITF) on EITF Issue 08-4, “Transition Guidance for
Conforming Changes to Issue No. 98-5,” to provide transition guidance for
conforming changes made to the abstract for EITF Issue 98-5, “Accounting
for Convertible Securities with Beneficial Conversion Features or
Contingently Adjustable Conversion Ratios,” relating to EITF Issue 00-27,
“Application of Issue No. 98-5 to Certain Convertible Instruments,” and
FASB Statement 150, Accounting for Certain Financial Instruments
with
Characteristics of both Liabilities and Equity. The Company intends
to
adopt EITF Issue 08-4 effective June 30, 2009 and apply its provisions
retrospectively to all periods presented in its financial statements.
The
Company is in the process of evaluating the impact that the adoption
of
the EITF Issue will have on its financial
statements.
|
Off-Balance
Sheet Arrangements
None
ITEM
1. LEGAL PROCEEDINGS
In
the
course of normal business, the Company may be subject to the threat of
litigation, claims and assessments. Management believes that unfavorable
decisions in any pending procedures or threat of procedures or any amount it
might be required to pay might have a material adverse impact on our financial
condition.
On
February 7, 2007, a lawsuit was filed by a former employee under Quebec Law
in
the Superior Court of Quebec for a total amount of $256,819 (CAD $273,307),
with
regards to alleged breach of employment contract and wrongful dismissal. The
Company has filed its response, and is in the process of contesting the case
vigorously. Furthermore, a court date for the hearing has been
scheduled.
Avensys
is not a party to any other pending legal proceeding, nor is its property the
subject of a pending legal proceeding, that is not in the ordinary course of
business or otherwise material to the financial condition of Avensys’
business.
ITEM
2. RECENT SALES OF UNREGISTERED SECURITIES
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
ITEM
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
ITEM
5. OTHER INFORMATION
On
September 29, 2008, the Company filed a Form 12b-25, relating to the late filing
of the Company’s 10-K report, since the Company’s financial information on a
consolidated basis could not be completed without resolving certain
accounting issues relating to the valuation and presentation of certain balance
sheet items. The Company resolved these accounting issues and filed its year-end
Form 10-K report on October 17, 2008.
ITEM
6. EXHIBITS AND REPORTS ON FORM 8-K
3.1
Articles of Incorporation of Avensys Corporation dated June 22, 2000 (as
incorporated by reference to Form SB-2 filed with the Securities and Exchange
Commission on September 29, 2000).
3.2
Bylaws of Avensys Corporation dated July 13, 2000 (as incorporated by reference
to Form SB-2 filed with the Securities and Exchange Commission on September
29,
2000).
3.3
Avensys Corporation Specimen Stock Certificate (as incorporated by reference
to
Form SB-2 filed with the Securities and Exchange Commission on September 29,
2000).
3.4
Amended Articles of Incorporation (as incorporated by reference from our Form
8-K filed with the Securities and Exchange Commission on March 18,
2003).
3.5
Amended Articles of Incorporation (as incorporated by reference to the Issuer's
Form SB-2 filed with the Securities and Exchange Commission on November 7,
2005).
3.6
Amended and Restated Bylaws dated February 13, 2007. (as incorporated by
reference to Current Report on Form 8-K filed with the Securities and Exchange
Commission on February 20, 2007).
10.1
Form
of Toll Cross Securities Warrant (as incorporated by reference to the Issuer's
Form SB-2 filed with the Securities and Exchange Commission on October 22,
2007).
10.2
Form
of Securities Purchase and Loan Agreement (as incorporated by reference to
the
Issuer's Form 8-K filed with the Securities and Exchange Commission on September
28 2007).
10.3
Form
of the 6 % Original Issue Discount Senior Secured Note (as incorporated by
reference to the Issuer's Form 8-K filed with the Securities and Exchange
Commission on September 28, 2007).
10.4
Form
of Imperium Warrant (as incorporated by reference to the Issuer's Form 8-K
filed
with the Securities and Exchange Commission on September 28, 2007).
10.5
Form
of Imperium Advisory Warrant (as incorporated by reference to the Issuer's
Form
8-K filed with the Securities and Exchange Commission on August 28,
2007).
10.6
Form
of Registration Rights Agreement (as incorporated by reference to the Issuer's
Form 8-K filed with the Securities and Exchange Commission on September 28,
2007).
10.7
Form
of Working Capital Note (as incorporated by reference to the Issuer's Form
8-K
filed with the Securities and Exchange Commission on September 28,
2007).
10.8
Form
of Security Agreement (as incorporated by reference to the Issuer's Form 8-K
filed with the Securities and Exchange Commission on September 28,
2007).
31.1
Certification of Principal Executive Officer pursuant to Rule 13a-15(e) and
Rule
15d-15(e), promulgated under the Securities Exchange Act of 1934, as
amended.
31.2
Certification of Principal Financial Officer pursuant to Rule 13a-15(e) and
Rule
15d-15(e), promulgated under the e Securities Exchange Act of 1934, as
amended.
32.1
Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section
906 Of The Sarbanes-Oxley Act of 2002 (Chief Executive Officer).
32.2
Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section
906 Of The Sarbanes-Oxley Act of 2002 (Chief Financial
Officer).
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused
this
report to be signed on its behalf by the undersigned, thereunto duly authorized
on this 14
th
day of
November, 2008.
AVENSYS
CORPORATION
(Registrant)
|
|
|
|
|
BY:
|
/s/
John Fraser
|
|
John
Fraser, President and Chief Executive
Officer
(Principal Executive
Officer)
|
|
|
BY:
|
/s/
André Maréchal
|
|
André
Maréchal, Chief Financial Officer,
|
|
(Principal
Financial and Accounting Officer)
|
Manaris 2010 (CE) (USOTC:AVNY)
Historical Stock Chart
From Jan 2025 to Feb 2025
Manaris 2010 (CE) (USOTC:AVNY)
Historical Stock Chart
From Feb 2024 to Feb 2025